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Introduction {#embj2018100926-sec-0001}
============

Interferon gamma (IFNγ) plays a pivotal role in antimicrobial defense, and loss‐of‐function mutations in IFNγ‐receptor signaling in the human and mouse result in severe susceptibility to infections, including by bacteria and microbial parasites (Altare *et al*, [1998](#embj2018100926-bib-0001){ref-type="ref"}; Levin & Newport, [1999](#embj2018100926-bib-0050){ref-type="ref"}; Janssen *et al*, [2002](#embj2018100926-bib-0039){ref-type="ref"}). IFNγ‐priming of macrophages, which is crucial in restricting pathogen growth and controlling infection, upregulates key antimicrobial molecules that mediate cell‐intrinsic control of pathogens (Mosser & Edwards, [2008](#embj2018100926-bib-0064){ref-type="ref"}; MacMicking, [2012](#embj2018100926-bib-0055){ref-type="ref"}; Randow *et al*, [2013](#embj2018100926-bib-0076){ref-type="ref"}) and enhances pyroptotic cell death (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}; Meunier *et al*, [2014](#embj2018100926-bib-0060){ref-type="ref"}; Pilla *et al*, [2014](#embj2018100926-bib-0071){ref-type="ref"}; Finethy *et al*, [2015](#embj2018100926-bib-0023){ref-type="ref"}; Santos *et al*, [2018](#embj2018100926-bib-0084){ref-type="ref"}).

Among the most abundant IFNγ‐induced immune proteins are the guanylate binding proteins (GBPs), a family of large GTPases (65--72 kDa) which restrict bacterial replication and promote inflammasome signaling (Kim *et al*, [2011](#embj2018100926-bib-0043){ref-type="ref"}; Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}; Meunier & Broz, [2016](#embj2018100926-bib-0062){ref-type="ref"}; Pilla‐Moffett *et al*, [2016](#embj2018100926-bib-0072){ref-type="ref"}; Ngo & Man, [2017](#embj2018100926-bib-0065){ref-type="ref"}). The human genome harbors 7 *GBP* genes, among which GBP1‐5 are the most ubiquitously expressed members and GBP6 and 7 are only found in epithelial cells lining mucosal surfaces of the lung and intestines (Uhlen *et al*, [2015](#embj2018100926-bib-0093){ref-type="ref"}). In contrast, the mouse genome encodes 11 *Gbps* at two separate chromosomal loci (chr 3 and chr 5), whose protective roles have been revealed through studies on mice lacking *Gbp1, Gbp2, Gbp5,* or all *Gbps* on Chr3 (Degrandi *et al*, [2007](#embj2018100926-bib-0017){ref-type="ref"}, [2013](#embj2018100926-bib-0018){ref-type="ref"}; Kim *et al*, [2011](#embj2018100926-bib-0043){ref-type="ref"}; Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}; Yamamoto *et al*, [2012](#embj2018100926-bib-0102){ref-type="ref"}; Lindenberg *et al*, [2017](#embj2018100926-bib-0053){ref-type="ref"}). Mouse mGbp1, 2, 3, 5, 6, 7, 9, and 10 can be recruited to vacuoles of bacteria such as *Salmonella, Listeria, Francisella, Mycobacterium, Chlamydia,* and *Legionella* (Kim *et al*, [2011](#embj2018100926-bib-0043){ref-type="ref"}; Degrandi *et al*, [2013](#embj2018100926-bib-0018){ref-type="ref"}; Haldar *et al*, [2014](#embj2018100926-bib-0036){ref-type="ref"}; Meunier *et al*, [2014](#embj2018100926-bib-0060){ref-type="ref"}, [2015](#embj2018100926-bib-0061){ref-type="ref"}; Feeley *et al*, [2017](#embj2018100926-bib-0021){ref-type="ref"}; Finethy *et al*, [2017](#embj2018100926-bib-0024){ref-type="ref"}; Lindenberg *et al*, [2017](#embj2018100926-bib-0053){ref-type="ref"}) or parasites such as *Toxoplasma gondii* (*Tg*; Degrandi *et al*, [2007](#embj2018100926-bib-0017){ref-type="ref"}; Virreira Winter *et al*, [2011](#embj2018100926-bib-0096){ref-type="ref"}; Kravets *et al*, [2012](#embj2018100926-bib-0046){ref-type="ref"}, [2016](#embj2018100926-bib-0047){ref-type="ref"}; Selleck *et al*, [2013](#embj2018100926-bib-0086){ref-type="ref"}; Haldar *et al*, [2015](#embj2018100926-bib-0037){ref-type="ref"}). Human GBP1, 2, and 5 have a C‐terminal CaaX motif that can be isoprenylated to facilitate membrane recruitment (Britzen‐Laurent *et al*, [2010](#embj2018100926-bib-0006){ref-type="ref"}). Additionally, GTPase activity and GBP oligomerization, which depend on critical amino acids, have been studied biochemically before and need to be characterized in infected human macrophages (Daumke & Praefcke, [2016](#embj2018100926-bib-0016){ref-type="ref"}; Shydlovskyi *et al*, [2017](#embj2018100926-bib-0089){ref-type="ref"}). Murine Gbps facilitate the release of microbial ligands, such as LPS or DNA, and promote pyroptosis (Meunier *et al*, [2014](#embj2018100926-bib-0060){ref-type="ref"}, [2015](#embj2018100926-bib-0061){ref-type="ref"}; Pilla *et al*, [2014](#embj2018100926-bib-0071){ref-type="ref"}; Haldar *et al*, [2015](#embj2018100926-bib-0037){ref-type="ref"}; Man *et al*, [2015](#embj2018100926-bib-0058){ref-type="ref"}; Feeley *et al*, [2017](#embj2018100926-bib-0021){ref-type="ref"}; Finethy *et al*, [2017](#embj2018100926-bib-0024){ref-type="ref"}; Piro *et al*, [2017](#embj2018100926-bib-0073){ref-type="ref"}). However, mGbp2 can promote LPS detection by caspase‐11 independently of bacterial lysis (Pilla *et al*, [2014](#embj2018100926-bib-0071){ref-type="ref"}). Similarly, GBP5/mGbp5 has been implicated in the regulation of NLRP3 activation by pathogenic bacteria and soluble inflammasome priming agents (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}), and caspase‐11‐driven responses to LPS‐containing outer membrane vesicles (OMVs; Santos *et al*, [2018](#embj2018100926-bib-0084){ref-type="ref"}). Strikingly, how human macrophages are equipped to defend themselves against bacterial or parasitic pathogen infections, via the breadth of roles the human GBPs play, remains unstudied. Recent studies have shown cell type‐specific roles of human GBPs which underscore the need for defining the roles of GBPs in macrophages during infection (Al‐zeer *et al*, [2013](#embj2018100926-bib-0002){ref-type="ref"}; Johnston *et al*, [2016](#embj2018100926-bib-0040){ref-type="ref"}; Qin *et al*, [2017](#embj2018100926-bib-0074){ref-type="ref"}).

Inflammasomes are multimolecular complexes that activate caspase‐1 in response to microbial or danger/damage‐associated signals (Broz & Dixit, [2016](#embj2018100926-bib-0008){ref-type="ref"}). In specific contexts, such as infection by Gram‐negative bacteria, caspase‐4 and caspase‐8 can regulate the assembly of inflammasomes and caspase‐1 activation (Kayagaki *et al*, [2011](#embj2018100926-bib-0042){ref-type="ref"}; Rathinam Vijay *et al*, [2012](#embj2018100926-bib-0077){ref-type="ref"}; Man *et al*, [2013](#embj2018100926-bib-0056){ref-type="ref"}; Gurung *et al*, [2014](#embj2018100926-bib-0035){ref-type="ref"}; Antonopoulos *et al*, [2015](#embj2018100926-bib-0003){ref-type="ref"}; Viganò *et al*, [2015](#embj2018100926-bib-0095){ref-type="ref"}). The release of *Francisella* DNA by mGbp2 and mGbp5 is detected by the DNA‐binding protein AIM2, which activates caspase‐1 in mouse macrophages through the adaptor protein ASC (Man *et al*, [2015](#embj2018100926-bib-0058){ref-type="ref"}; Meunier *et al*, [2015](#embj2018100926-bib-0061){ref-type="ref"}). However, recent studies in primary human myeloid cells have suggested that cytosolic DNA stimulates a cGAS‐STING‐dependent pathway that results in secondary NLRP3 activation, whereas AIM2 was dispensable (Fernandes‐Alnemri *et al*, [2009](#embj2018100926-bib-0022){ref-type="ref"}; Gaidt *et al*, [2017](#embj2018100926-bib-0027){ref-type="ref"}).

IFNγ‐signaling deficiency in mice results in extreme susceptibility to infection by the eukaryotic pathogen *Tg* and the Gram‐negative bacterial pathogen *Salmonella enterica* Typhimurium (STm), among others (Jouanguy *et al*, [1999](#embj2018100926-bib-0041){ref-type="ref"}; Hunter & Sibley, [2012](#embj2018100926-bib-0038){ref-type="ref"}). *Tg* infection causes chronic disease that can lead to death in the immunocompromised and fetal abnormalities in cases of the mother acquiring a primary infection during pregnancy (Pappas *et al*, [2009](#embj2018100926-bib-0070){ref-type="ref"}; Torgerson & Mastroiacovo, [2013](#embj2018100926-bib-0092){ref-type="ref"}). STm is a broad host‐range pathogen that causes gastrointestinal disease in humans (Coburn *et al*, [2007](#embj2018100926-bib-0013){ref-type="ref"}). Human IFNγ deficiency also results in sensitivity to environmental salmonellae (Jouanguy *et al*, [1999](#embj2018100926-bib-0041){ref-type="ref"}), pointing to a need to better understand the response of human cells and IFNγ‐mediated responses to these pathogens.

Both pathogens can induce cell death in the infected cell, which may promote the spread of infection within the host (Coburn *et al*, [2007](#embj2018100926-bib-0013){ref-type="ref"}; Krishnamurthy *et al*, [2017](#embj2018100926-bib-0048){ref-type="ref"}). *Tg‐*induced host‐cell death can vary depending on the host species and IFNγ‐priming; mechanisms including pyroptosis and inhibition of apoptosis have been reported in *Tg‐*infected naïve rodent and human cells. However, the response of human IFNγ‐primed macrophages to *Tg* remains unclear. STm activates the NLRC4 and NLRP3 inflammasomes in mouse and human macrophages (Broz *et al*, [2010](#embj2018100926-bib-0007){ref-type="ref"}; Man *et al*, [2014](#embj2018100926-bib-0057){ref-type="ref"}; Kortmann *et al*, [2015](#embj2018100926-bib-0045){ref-type="ref"}; Reyes Ruiz *et al*, [2017](#embj2018100926-bib-0078){ref-type="ref"}). Further, IFNγ‐priming of human macrophages enhances STm‐induced inflammasome activation (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}; Meunier *et al*, [2014](#embj2018100926-bib-0060){ref-type="ref"}; Santos *et al*, [2018](#embj2018100926-bib-0084){ref-type="ref"}). Whether other GBPs contribute to inflammasome responses to STm or *Tg* remains to be determined.

In this study, we systematically studied the roles of human GBPs in primary monocyte‐derived macrophages (MDMs) and PMA‐differentiated THP‐1 cells infected with *Tg* and STm. Notably, *Tg* infection in macrophages caused GBP1‐dependent apoptosis and STm infection led to GBP1‐dependent increase of pyroptosis. Our studies uncover a gatekeeping role for human GBP1 and expand the role of human GBPs in regulating other forms of cell death during natural infection by microbial pathogens.

Results {#embj2018100926-sec-0002}
=======

GBP1 is an essential mediator of macrophage cell death during *Toxoplasma* infection {#embj2018100926-sec-0003}
------------------------------------------------------------------------------------

We investigated the impact of IFNγ‐priming on host cell death in PMA‐differentiated human THP‐1 macrophage‐like cells upon infection with type I (RH) and type II (Pru) *Tg*, which differ in their virulence effector repertoire (Saeij *et al*, [2005](#embj2018100926-bib-0080){ref-type="ref"}). We found that 24 h post‐infection with both *Tg* strains IFNγ‐primed macrophages underwent enhanced cell death, as measured by lactate dehydrogenase (LDH) and XTT dye assays (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}A). We hypothesized that similar to their role in murine cells, GBPs could be involved in IFNγ‐enhanced macrophage death. Primary MDMs and THP‐1 cells treated with IFNγ express GBP1‐5 but not GBP6 or 7 (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}A), and both macrophage types also express low, but detectable, levels of GBP1 in the absence of IFNγ stimulation (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}B). We silenced individual GBP1--5 by siRNA transfection (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}C) and quantified type I and type II *Tg* infection‐induced cell death (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}B). Silencing of GBP1, but not other family members, abrogated *Tg‐*induced cell death suggesting an essential role for GBP1 in this process. GBP1 silencing in primary MDMs also abrogated *Tg‐*induced cell death further validating its role in human macrophages (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}C and [Appendix Fig S1A](#embj2018100926-sup-0001){ref-type="supplementary-material"}).

![GBP1, its GTPase activity, and isoprenylation are required for IFNγ‐enhanced cell death upon *Toxoplasma* infection\
IFNγ enhances macrophage host cell death after type I (RH) and type II (Pru) *Toxoplasma gondii* (*Tg*) infection. Graphs show cell death as measured by LDH release assay (left) and viability measured by XTT assay (right) in untreated or IFNγ‐primed THP‐1 cells infected with type I or type II *Tg* for 24 h.LDH release assays from THP‐1 cells left untreated or primed with IFNγ, transfected with siRNA against indicated *GBPs* or non‐targeting control (CTRL), and infected with indicated strains of *Tg* for 24 h.LDH release assay from primary monocyte‐derived macrophages (MDM) left untreated or treated with IFNγ, transfected with siRNA against *GBP1* or non‐targeting control (CTRL), and infected with indicated strain of *Tg* for 24 h. Mean ± SEM of *n* = 4 donors shown.LDH release assay from indicated wild‐type, *GBP1*‐knockout (Δ*GBP1*), or *GBP1*‐reconstituted (Δ*GBP1 *+* *Tet‐*GBP1*) cells infected with type I or type II *Tg* for 24 h. Cells were untreated or treated with IFNγ or additionally treated with Doxycycline (Dox) as indicated.Real‐time propidium iodide (PI) uptake assay from the indicated THP‐1 cells infected with type I or type II *Tg*, and untreated or treated with IFNγ and/or Dox as labeled. AU, arbitrary units.LDH release assay from wild‐type THP‐1 or Δ*GBP1* cells stably reconstituted with Dox‐inducible expression plasmids of the indicated mutants of GBP1. Cells were pre‐treated with IFNγ and Dox and infected with either type I or type II *Tg* for 24 h.Data information: Graphs in (A, B and D‐F) show mean ± SEM from *n* = 3 independent experiments. *\*P *≤ 0.05; *\*\*P *≤ 0.01*, \*\*\*P *≤ 0.001, *\*\*\*\*P* ≤ 0.0001 for indicated comparisons in (A--D) from two‐way ANOVA or comparison between THP‐1 WT and other genotypes by one‐way ANOVA in (F) following adjustment for multiple comparisons; ns, not significant.](EMBJ-38-e100926-g002){#embj2018100926-fig-0001}

![Quality control of GBP ablation in THP‐1 cells\
Fold‐change of mRNA of *GBP1‐7* compared to hypoxanthine phosphoribosyltransferase 1 (*HPRT1*) in PMA‐differentiated THP‐1 cells (left) and primary MDMs (right) following treatment with IFNγ (50 IU/ml). Mean (red bar) ± SEM of *n* = 14 experiments (THP‐1) or *n* = 6 experiment (MDMs) shown; n.d. not detected.Immunoblots from differentiated THP‐1 WT or MDMs treated with IFNγ (50 IU/ml) or left untreated. Images represent *n* = 3 independent experiments.qRT--PCR measurement of silencing of expression of the indicated *GBPs* in IFNγ‐primed THP‐1 cells transfected with siRNA against *GBP1‐5*. mRNA fold‐change (mean ± SEM; *n* = 3 independent experiments) normalized to *HPRT1* as percentage of cells transfected with non‐targeting control (CTRL) siRNA is indicated.Immunoblots from indicated THP‐1 cells treated with IFNγ. Images represent *n* = 3 independent experiments.qRT--PCR measurement of *GBP1‐5* expression in THP‐1 and THP‐1 Δ*GBP1* cells treated with IFNγ plotted as fold‐change to *HPRT1*. Mean ± SEM plotted from *n* = 3 experiments; n.d. not detected.RT--PCR amplification of *GBP1‐5* coding sequences (CDS) from indicated THP‐1 cells treated with IFNγ. Yellow arrowhead indicates the truncated GBP1 CDS in the Δ*GBP1* cells.Sequencing results showing loss of *GBP1* coding region. Top: Needleman‐Wunsch alignment of *GBP1* sequence from THP‐1 Δ*GBP1* and *GBP1* transcript sequence NM_002053.2 showing the deletion in knockout cells. Bottom left: *GBP1* CDS with deletion highlighted in red. qRT--PCR primer binding sites marked in blue and bold letters and amplicon marked in blue. Bottom right: Summary table of sequencing result of *GBP1‐5* in THP‐1 Δ*GBP1* cells confirming loss of *GBP1* and wild‐type coding sequences of *GBP2‐5*.](EMBJ-38-e100926-g003){#embj2018100926-fig-0001ev}

*GBP1‐*knockout THP‐1 (Δ*GBP1*) cells created with CRISPR/Cas9 (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}D), also failed to undergo cell death upon *Tg* infection and provided an independent verification of siRNA experiments (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}D). THP‐1 Δ*GBP1* cells were extensively characterized, and GBP2‐5 expression and sequences in THP‐1 Δ*GBP1* were similar to wild‐type THP‐1 cells (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}D--G). Genetic complementation of THP‐1 Δ*GBP1* cells was achieved using a Doxycycline (Dox)‐inducible expression system which mimicked IFNγ‐induced expression of GBP1 (Fig [EV2](#embj2018100926-fig-0002ev){ref-type="fig"}A--C). GBP1 protein abundance remained high over a 24‐h period with a protein half‐life of 6.3 h, which permitted Dox pre‐treatment and removal during the course of experiments (Fig [EV2](#embj2018100926-fig-0002ev){ref-type="fig"}D). Indeed, re‐expression of GBP1 (THP‐1 ∆*GBP1* + Tet‐*GBP1* cells) restored cell death in response to *Tg* infection, which provided additional support for siRNA and CRISPR/Cas9‐based experiments and underscored the role of GBP1 in cell death (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}D). Real‐time propidium iodide (PI) uptake assays, measuring membrane damage linked to cell death, revealed the kinetics of *Tg‐*induced cell death (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}E). These assays confirmed the requirement for IFNγ‐priming and the initiation of membrane damage \~ 6 h post‐*Tg* infection (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}E). Similarly, Dox‐induced expression of GBP1 was necessary for PI uptake in IFNγ‐primed THP‐1 Δ*GBP1 *+* *Tet‐*GBP1* cells (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}E).

![Doxycycline‐inducible re‐expression of GBP1 in THP‐1 Δ*GBP1*\
AGraphical overview of the Doxycycline‐inducible system. Tet‐activator rtTA2S‐M2 (TA), silencer tTS (TS), and bsr (encoding Blasticidin S resistance) are constitutively expressed using the Tet‐ctrl vector. In the absence of Doxycycline (Dox), TS binds to the response vector encoding GBP1 open reading frame under the control of heptameric tet‐operon (TetO7) and blocks GBP1 expression. Upon treatment with Dox, TA loses DNA binding capacity and TA induces GBP1 expression.B, CImmunoblots of GBP1 and β‐actin from THP‐1, THP‐1 Δ*GBP1*, and THP‐1 Δ*GBP1* stably transduced with Tet‐*GBP1* plasmid for Dox‐inducible GBP1 expression. Cells were treated with IFNγ and/or Dox as indicated in (B) or indicated concentrations of Dox in (C). Images represent *n* = 3 independent experiments.DImmunoblots of GBP1 and β‐actin and plot of GBP1 band intensity from THP‐1 Δ*GBP1 *+* *Tet‐*GBP1* cells pre‐treated with Dox (0.2 μg/ml) for 12 h, washed‐off, and cycloheximide (CHX; 50 μg/ml) added for times as indicated. Band intensities (mean ± SEM) quantified using FIJI of *n* = 3 independent experiments are plotted, and red line shows a non‐linear fit of the data. The predicted GBP1 half‐life τ = 6.33 h.EGraphical representation of GBP1 mutations and their biological effect mapped on the GBP1 primary structure (not to scale). NTHD = *N*‐terminal helical domain, CaaX = CaaX motif for prenylation. Amino acid positions in human GPB1 are indicated.FImmunoblots of GBP1 and β‐actin from THP‐1 wild‐type or THP‐1 Δ*GBP1* cells stably reconstituted with indicted Dox‐inducible GBP1 variants or empty vector (EV). Cells were treated with either IFNγ or Dox.](EMBJ-38-e100926-g005){#embj2018100926-fig-0002ev}

We next sought to determine the molecular determinants of GBP1 involved in cell death and tested this via mutational analyses. We employed the following GBP1 mutants: K51A lacking GTPase activity, RK227/228EE with constitutive homodimerization (Vöpel *et al*, [2010](#embj2018100926-bib-0097){ref-type="ref"}), K382R lacking a ubiquitination site, and C589A and Δ589--592 lacking the isoprenylation residue or the CaaX box, respectively (Vöpel *et al*, [2010](#embj2018100926-bib-0097){ref-type="ref"}; Shydlovskyi *et al*, [2017](#embj2018100926-bib-0089){ref-type="ref"}; Fig [EV2](#embj2018100926-fig-0002ev){ref-type="fig"}E and F). Notably, GBP1 variants with loss of GTPase activity (K51A) or isoprenylation (C589A or Δ589--592) were unable to restore *Tg‐*induced cell death in Δ*GBP1* cells (Fig [1](#embj2018100926-fig-0001){ref-type="fig"}F). Taken together, these experiments established that human GBP1 was required for macrophage cell death in response to infection by type I or type II *Tg* and its GTPase activity and isoprenylation were essential for this function.

*Toxoplasma* induces GBP1‐, AIM2‐, ASC‐, and caspase‐8‐dependent apoptosis in macrophages {#embj2018100926-sec-0004}
-----------------------------------------------------------------------------------------

*Tg‐*induced cell death in human macrophages is poorly characterized. To investigate mechanisms of cell death, we used pan‐caspase inhibitors during infection and found that they completely inhibited cell death (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}A). As GBPs are known to be involved in pyroptosis, and *Tg* infection of rodent macrophages causes pyroptosis via NLRP1 and NLRP3 (Cirelli *et al*, [2014](#embj2018100926-bib-0012){ref-type="ref"}; Ewald *et al*, [2014](#embj2018100926-bib-0020){ref-type="ref"}; Gorfu *et al*, [2014](#embj2018100926-bib-0031){ref-type="ref"}), we reasoned that human macrophages infected with *Tg* might also undergo pyroptosis. However, unexpectedly, cell death in IFNγ‐primed THP‐1 Δ*CASP1* or Δ*CASP4* CRISPR/Cas9‐knockout cells, or THP‐1 with stable silencing of gasdermin D (GSDMD; *GSDMD* ^miR^ cells), the pore forming protein responsible for pyroptosis, was comparable to that in wild‐type THP‐1 cells (Fig [2](#embj2018100926-fig-0002){ref-type="fig"}A). Maturation of caspase‐1 and IL‐1β or IL‐18 into their active forms could not be detected in *Tg‐*infected macrophages irrespective of the absence or presence of GBP1 (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}B and C). These findings together ruled out pyroptotic cell death 18 h after *Tg* infection. In contrast, THP‐1 Δ*ASC* cells were resistant to *Tg*‐induced cell death (Fig [2](#embj2018100926-fig-0002){ref-type="fig"}A). As ASC has previously been implicated in apoptosis, we measured apoptosis using an Annexin V (AnnV)‐Glo luminescence assay and performed immunoblots for caspases and the apoptotic substrate PARP. Indeed, IFNγ‐primed MDMs infected with *Tg* displayed marked apoptosis within 3 h post‐infection, which preceded PI uptake induced by post‐apoptotic necrotic membrane damage (Silva, [2010](#embj2018100926-bib-0090){ref-type="ref"}; Fig [2](#embj2018100926-fig-0002){ref-type="fig"}B). Further, primary MDMs transfected with GBP1 siRNA failed to show increased AnnV‐Glo upon *Tg* infection (Fig [2](#embj2018100926-fig-0002){ref-type="fig"}B and [Appendix Fig S1A](#embj2018100926-sup-0001){ref-type="supplementary-material"}). Similarly, wild‐type, but not THP‐1 Δ*GBP1* cells, showed increased AnnV‐Glo in response to *Tg* infection (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}D). Flow cytometry‐based quantification of apoptosis using AnnV staining provided concordant results showing elevated apoptosis upon IFNγ‐priming and lack of apoptosis in Δ*GBP1* cells (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}E). We used TNFα plus cycloheximide (CHX) or staurosporine as positive controls to induce apoptosis, which not only verified our assays, but also indicated that wild‐type and THP‐1 Δ*GBP1* cells do not have broad defects in extrinsic or intrinsic apoptosis (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}F). These findings indicated that GBP1 was specifically involved in microbe‐dependent apoptosis. Immunoblots from MDMs and THP‐1 cells infected with type I and type II *Tg* revealed the presence of cleaved caspase‐3, caspase‐6, caspase‐7 and caspase‐8, and cleaved PARP (Figs [2](#embj2018100926-fig-0002){ref-type="fig"}C and [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}G). Live time‐lapse imaging showed a temporal increase of caspase‐3/7 activity, shrinking of the cells, and the presence of apoptotic bodies upon infection with type I or type II *Tg* (Fig [2](#embj2018100926-fig-0002){ref-type="fig"}D and E). The presence of nuclear fragmentation and condensation of chromatin further supported apoptotic cell death during *Tg* infection (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}H). These experiments unequivocally established that *Tg*‐infected human macrophages undergo apoptosis in a GBP1‐ and ASC‐dependent manner.

![*Toxoplasma* infection induces apoptosis in human macrophages\
Propidium iodide (PI) uptake assay of naïve or IFNγ‐primed THP‐1 cells infected with either type I or type II *Toxoplasma gondii* (*Tg*) for 18 h in the absence or presence of pan‐caspase inhibitors zVAD‐fmk (25 μM) or qVD (20 μM). Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments.Immunoblots of the indicated proteins from THP‐1 WT or ∆*GBP1* cells infected with type I and type II *Tg* for 6 h or left uninfected (UI). Cells were unprimed or primed with IFNγ as indicated. Cells were treated with Nigericin (Nig., 10 μM for 2 h) to activate the NLRP3--caspase‐1 pathway as a positive control. Images represent *n* = 3 independent experiments.ELISA for IL‐1β (left) or IL‐18 (middle) from IFNγ‐primed THP‐1 cells or IL‐1β from primary MDMs infected with *Tg* for 24 h. Mean ± SEM are shown from *n* = 6 experiments (IL‐1β ELISA THP‐1), 3 experiments (IL‐18 ELISA THP‐1), and 4 donors of MDMs. Dashed lines for the +IFNγ data points indicate matching values from the same experiment.Real‐time annexin V (AnnV)‐Glo assay from indicated IFNγ‐primed THP‐1 cells left uninfected or infected with type I or type II *Tg* for 18 h. Area under the curve (AUC) from real‐time assays plotted as mean ± SEM from *n* = 3 independent experiments.Quantification of apoptosis by the AnnV‐staining assay in indicated THP‐1 cells infected with *Tg*. Upper panels show representative flow cytometry scatter plots of unprimed or IFNγ‐primed THP‐1 cells uninfected or infected with GFP‐expressing *Tg* strains as indicated. Cells were gated for single cells and GFP. Graph (below) shows the quantification (mean ± SEM from *n* = 3 independent experiments) of flow cytometry data of AnnV^+^ cells.AnnV‐Glo assay of THP‐1 WT, Δ*GBP1,* and Δ*GBP1* cells stably reconstituted with Tet‐wild‐type GBP1 or GBP1^K51A^, GBP1^C589A^, or GBP1^Δ589--592^ mutants as indicated, left untreated, or treated with Staurosporine (Sts) or TNFα + cycloheximide (TNFα + CHX) for 18 h. Area under the curve (AUC) from real‐time assays plotted as mean ± SEM from *n* = 3 independent experiments.Immunoblot of IFNγ‐primed THP‐1 infected with type I or type II *Tg* for 12 h. As positive control, cells were treated with TNFα + CHX. Representative image of *n* = 2 experiments.Representative immunofluorescence images of IFNγ‐primed THP‐1 WT cells infected with type I or type II *Tg* (gray) at 12 h post‐infection. Merged fluorescence and bright‐field image (left) and fluorescence only (right) are shown. Yellow arrowheads, apoptotic nuclei; Dotted line, cell outline; Gray, differential interference contrast; Blue, nuclei; Green, *Tg*. Scale bar, 20 μm.Immunoblot of IFNγ‐primed THP‐1 infected with type I or type II *Tg* for the indicated time.Data information: *\*P* ≤ 0.05; *\*\*P* ≤ 0.01, *\*\*\*\*P* ≤ 0.0001 in (A, C) from two‐way ANOVA following adjustment for multiple comparisons; ns, not significant.](EMBJ-38-e100926-g007){#embj2018100926-fig-0003ev}

![GBP1 promotes ASC‐ and CASP8‐dependent atypical apoptosis in *Toxoplasma*‐infected human macrophages\
APropidium iodide (PI) uptake in wild‐type THP‐1 or Δ*CASP1*, Δ*CASP4*, Δ*ASC* cells, or THP‐1 stably expressing *GSDMD*‐targeting miRNA (*GSDMD* ^*miR*^) infected with the indicated strains of *Toxoplasma gondii* (*Tg*) for 24 h. Cells were untreated or treated with IFNγ as indicated. Mean area under the curve (AUC) ± SEM from *n* = 3 experiments are shown. ns, not significant, from two‐way ANOVA following adjustment for multiple comparisons.BReal‐time apoptosis assay (Annexin V (AnnV)‐Glo luminescence) from IFNγ‐primed primary human MDMs transfected with non‐targeting control (siCTRL; left) or *GBP1* siRNA (si*GBP1*; right) and left uninfected or infected with type I or type II *Tg*. Depicted is the mean ± SEM of *n* = 4 donors. AU, arbitrary units.CImmunoblots from primary MDMs infected with the indicated *Tg* strains for 12 h. Cells were untreated or pre‐treated with IFNγ before infection. Treatment with TNFα and cycloheximide (CHX) served as positive control for apoptosis. Images are representative of *n* = 4 biologically independent experiments.D, ELive time‐lapse imaging to visualize apoptotic cell death and measure caspase‐3/7 activities using a fluorescent caspase substrate. THP‐1 WT were primed with IFNγ or left untreated and infected with either type I or type II *Tg*. Plot in (D) shows cumulative caspase‐3/7 activity from an 18‐h time course (mean ± SEM from *n* = 3 independent experiments). Representative phase‐contrast images overlaid with fluorescence signal for caspase‐3/7 activity (green) images are shown in (E) from IFNγ‐primed THP‐1 cells infected with type I *Tg* captured at indicated times post‐infection. Scale bar 20 μm.FAnnV‐Glo assay from IFNγ‐primed THP‐1 transfected with siRNA against the indicated human caspases and infected with type I or type II *Tg*. Area under the curve (AUC) from a real‐time AnnV‐Glo luminescence assays similar to those in (B) is plotted as mean ± SEM from *n* = 3 independent experiments. *\*P* ≤ 0.05, *\*\*\*P* ≤ 0.001, *\*\*\*\*P *≤ 0.0001 from two‐way ANOVA for indicated comparisons following adjustment for multiple comparisons; ns, not significant.GAnnV‐Glo assay from IFNγ‐primed primary human MDMs transfected with siRNA against *CASP8, CASP10,* and non‐targeting control (CTRL) and infected with type I or type II *Tg*. Area under the curve (AUC) from real‐time assays similar to those in (B) are plotted from *n* = 4 independent experiments. Matched shapes and color of symbols indicate donors. *\*\*\*\*P* ≤ 0.0001 from two‐way ANOVA following adjustment for multiple comparisons; ns, not significant.\
Source data are available online for this figure.](EMBJ-38-e100926-g004){#embj2018100926-fig-0002}

We next asked which caspase mediated apoptosis in *Tg‐*infected macrophages? We therefore performed a family‐wide RNAi screen against caspases to assess their involvement. Silencing of caspase‐8 or caspase‐10 in THP‐1 cells reduced *Tg*‐induced apoptosis (Fig [2](#embj2018100926-fig-0002){ref-type="fig"}F and [Appendix Fig S1B](#embj2018100926-sup-0001){ref-type="supplementary-material"}). Although caspase‐8 was also required for *Tg‐*induced apoptosis in primary MDMs, caspase‐10, which is a human‐specific caspase, was dispensable (Fig [2](#embj2018100926-fig-0002){ref-type="fig"}G and [Appendix Fig S1A](#embj2018100926-sup-0001){ref-type="supplementary-material"}). Silencing of caspase‐8 also inhibited cell death in *Tg*‐infected THP‐1 ∆*CASP1* and ∆*CASP4,* which ruled out a role for these caspases in the process (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}A). We therefore concluded that caspase‐8 was essential for apoptosis upon *Tg* infection. To investigate the potential role of an NLR/ALR that could detect *Tg* infection and induce apoptosis via the adaptor ASC, we used RNAi against common NLRs and AIM2. RNAi experiments in THP‐1 cells revealed that silencing of AIM2, but not NLRP1, NLRP3, or NLRC4, abolished apoptosis (Fig [3](#embj2018100926-fig-0003){ref-type="fig"}A and [Appendix Fig S1B](#embj2018100926-sup-0001){ref-type="supplementary-material"}). AIM2 silencing also led to diminished apoptosis in *Tg*‐infected primary MDMs (Fig [3](#embj2018100926-fig-0003){ref-type="fig"}B and [Appendix Fig S1A](#embj2018100926-sup-0001){ref-type="supplementary-material"}). We therefore concluded that *Tg*‐infected human macrophages undergo *GBP1‐, AIM2‐, ASC‐*, and *CASP8‐*driven apoptosis.

![*Toxoplasma* infection blocks pyroptosis, but GBP1 enhances *Salmonella*‐induced pyroptosis via caspase‐4\
AAnnV‐Glo assay of IFNγ‐primed THP‐1 WT, Δ*CASP1, or* ∆*CASP4* cells transfected with siCTRL or si*CASP8* and infected with either type I or type II *Toxoplasma gondii* (*Tg*) for 18 h. Area under the curve (AUC) from real‐time assays plotted as mean ± SEM from *n* = 3 independent experiments.BPropidium iodide (PI) uptake assay from naïve or IFNγ‐primed THP‐1 left uninfected or infected with type I or type II *Tg* for 4 h. Cells were treated with nigericin at 2 h post‐infection to activate NLRP3--caspase‐1. Area under the curve (AUC) from real‐time assays plotted as mean ± SEM from *n* = 3 independent experiments.CAnnV‐Glo assay of THP‐1 Δ*GBP1 + Tet‐GBP1* cells left untreated or treated with IFNγ, Doxycycline (Dox), or both and infected with either type I or type II *Tg* for 18 h. Area under the curve (AUC) from real‐time assays plotted as mean ± SEM from *n* = 3 independent experiments.DLDH release assays from A549 epithelial cells primed with IFNγ or left untreated and infected type I or type II *Tg* for 24 h or uninfected (UI). As positive control, cells were treated with TNFα and cycloheximide (CHX). Mean ± SEM from *n* = 3 independent experiments.ELDH release assay (left) or PI uptake assay (right) from IFNγ‐primed or untreated THP‐1 WT infected with *Salmonella* Typhimurium (STm) or STm‐GFP (MOI = 30) for 4 h. Mean ± SEM of LDH assay or from area under the curve (AUC) of the PI uptake real‐time assays plotted from *n* = 3 independent experiments.F, GLDH release assays (F) or IL‐1β ELISA (G) from THP‐1 and primary MDMs primed with IFNγ and infected with STm‐GFP (MOI = 30) at 4 h post‐infection. Mean ± SEM from *n* = 3 (THP‐1) or *n* = 4 (MDMs) independent experiments plotted.HPI uptake assay of THP‐1‐, Δ*CASP1‐*, Δ*CASP4‐,* or *GSDMD‐*silenced cells (*GSDMD* ^*miR*^) primed with IFNγ and infected with STm‐GFP. Mean ± SEM from area under the curve (AUC) of 4 h real‐time assays plotted from *n* = 3 independent experiments.IPI uptake assay from IFNγ‐primed THP‐1 Δ*GBP1 + Tet‐GBP1* cells transfected with non‐targeting control (CTRL) or *CASP1*,*CASP4,* and *GSDMD* siRNA and infected with STm‐GFP for 4 h. Mean ± SEM from area under the curve (AUC) from real‐time assays plotted from *n* = 3 independent experiments.JPI uptake assay of IFNγ‐primed THP‐1 or THP‐1 Δ*GBP1* cells stably expressing indicated mutants of GBP1 (Δ*GBP1 *+* *Tet‐*GBP1*) treated with Dox and treated with Nigericin to induce NLRP3‐dependent pyroptosis. Mean ± SEM from area under the curve (AUC) of 4‐h real‐time assays plotted from *n* = 3 independent experiments.KImmunoblots of GBP1, YFP, and β‐actin from THP‐1 Δ*GBP1 *+* *Tet‐mCH‐*GBP1* and THP‐1 Δ*GBP1 *+* *Tet‐mCH‐*GBP1* stably transduced with YFP‐*CASP4* ^C258S^. Cells were treated with IFNγ and/or Dox as indicated. Images represent *n* = 3 independent experiments.Data information: *\*P* ≤ 0.05; *\*\*P* ≤ 0.01, *\*\*\*P* ≤ 0.001, *\*\*\*\*P* ≤ 0.0001 from two‐way ANOVA following adjustment for multiple comparisons; ns, not significant.](EMBJ-38-e100926-g009){#embj2018100926-fig-0004ev}

![*Toxoplasma*‐infected human macrophages die through AIM2‐dependent atypical apoptosis\
AnnV‐Glo assay from IFNγ‐primed THP‐1 transfected with siRNA against the indicated human NLR/ALR sensors and infected with type I or type II *Toxoplasma gondii* (*Tg*). Area under the curve (AUC) from real‐time assays is plotted as mean ± SEM from *n* = 3 independent experiments. *\*\*\*\*P* ≤ 0.0001 from two‐way ANOVA for indicated comparisons following adjustment for multiple comparisons; ns, not significant.AnnV‐Glo assay from IFNγ‐primed primary human MDMs transfected with siRNA against *AIM2* or non‐targeting control (CTRL) and infected with type I or type II *Tg*. Area under the curve (AUC) from real‐time assays is plotted from *n* = 4 independent experiments. Matched shapes and color of symbols indicate donors. *\*\*\*\*P *≤ 0.0001 from two‐way ANOVA for indicated comparisons following adjustment for multiple comparisons; ns, not significant.Representative images (top) from IFNγ‐primed THP‐1 WT infected with type I *Tg* for 8 h and stained for ASC and active caspase‐8. Blue, Nuclei; Red, ASC; Green, active caspase‐8 (IETD‐FITC); and Gray, *Tg*. Scale bar, 5 μm or 2 μm in the magnified images. Quantification of ASC specks (bottom) in *Tg*‐infected THP‐1 WT or ∆*CASP1* treated with IFNγ or left untreated at 8 h post‐infection, plotted as mean ± SEM from *n* = 3 independent experiment.Immunoblots from primary MDMs infected with *Tg* strains for the indicated times. Cells were untreated or pre‐treated with IFNγ before infection. Images are representative of *n* = 4 biologically independent experiments.\
Source data are available online for this figure.](EMBJ-38-e100926-g006){#embj2018100926-fig-0003}

AIM2 forms oligomeric inflammasome "specks" for caspase‐1 activation. Indeed, \~ 20% of *Tg*‐infected macrophages had ASC specks; however, 95% of these also recruited caspase‐8 (Fig [3](#embj2018100926-fig-0003){ref-type="fig"}C). Like Tg‐induced apoptosis, the formation of ASC--caspase‐8 specks was dependent on IFNγ treatment and independent of caspase‐1 (Fig [3](#embj2018100926-fig-0003){ref-type="fig"}C). Next, we wanted to investigate why AIM2 and ASC did not activate caspase‐1 as is typical of AIM2 activation. Immunoblots of *Tg*‐infected MDMs (Fig [3](#embj2018100926-fig-0003){ref-type="fig"}D) and THP‐1 (Fig [EV3](#embj2018100926-fig-0003ev){ref-type="fig"}I) cells revealed loss of caspase‐1, NLRP1, NLRP3, NLRC4 proteins over a time course of 6 h. In agreement with reduced NLRP3 abundance, *Tg*‐infected cells responded poorly to the NLRP3 inflammasome‐activating toxin nigericin (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}B). Importantly, the abundance of AIM2, whose expression was upregulated by IFNγ, was unchanged during the course of *Tg* infection. These results also implied that without IFNγ‐priming, because of the absence of AIM2 expression, GBP1 expression alone would not be sufficient for cell death. We tested this experimentally by treating THP‐1 Δ*GBP1* + Tet‐GBP1 cells with Dox to induce GBP1 expression and infected them with *Tg*. Indeed, heterologous GBP1 expression without IFNγ‐priming did not restore apoptosis in THP‐1 Δ*GBP1 *+ Tet‐GBP1 cells (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}C). In conclusion, these results showed that GBP1 mediated atypical apoptosis via AIM2‐ASC‐caspase‐8 in *Tg*‐infected human macrophages.

GBP1 is recruited to pathogen‐containing vacuoles in a GTPase activity and isoprenylation‐dependent manner {#embj2018100926-sec-0005}
----------------------------------------------------------------------------------------------------------

Whether human GBP1 targets microbial vacuoles in macrophages is not known. Murine Gbps in general and human GBPs in some cell lines are recruited to bacterial and *Tg* vacuoles (Coers, [2017](#embj2018100926-bib-0014){ref-type="ref"}; Man *et al*, [2017](#embj2018100926-bib-0059){ref-type="ref"}; Saeij & Frickel, [2017](#embj2018100926-bib-0081){ref-type="ref"}; Santos & Broz, [2018](#embj2018100926-bib-0083){ref-type="ref"}). As we identified atypical apoptosis via GBP1 and AIM2, we asked whether GBP1 was recruited to *Tg* parasitophorous vacuoles (PVs) and whether this was required for apoptosis. Endogenous GBP1 in MDMs was recruited to *Tg* PVs in an IFNγ‐dependent manner (Fig [4](#embj2018100926-fig-0004){ref-type="fig"}A and B). Similarly, Dox‐inducible expression of mCherry (mCH)‐tagged GBP1 in THP‐1 Δ*GBP1* targeted to the PV upon IFNγ treatment (Fig [4](#embj2018100926-fig-0004){ref-type="fig"}A and B). We also tested whether the mutants GBP1^K51A^, GBP1^C589A^, and GBP1^Δ589--592^, which did not support apoptosis, targeted to PVs. All three mutants failed to decorate *Tg* PVs, thus correlating with their inability to promote apoptosis (Fig [4](#embj2018100926-fig-0004){ref-type="fig"}A and B). Notably, we did not observe cell death in IFNγ‐treated A549 cells infected with *Tg* (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}D). We previously showed that in A549 cells, GBP1 does not traffic to *Tg* vacuoles but is required for restricting *Tg* replication (Johnston *et al*, [2016](#embj2018100926-bib-0040){ref-type="ref"}). This indicated that even though cell death requires GBP1‐targeting of PVs, growth restriction is independent of this process. We therefore propose that PV targeting is required for GBP1‐dependent apoptosis during *Tg* infection.

![GBP1 targets *Toxoplasma* vacuoles in human macrophages\
A, BRepresentative images (A) and quantification (B) from IFNγ‐primed THP‐1 Δ*GBP1* stably reconstituted with Tet‐mCH‐*GBP1*, mCH‐*GBP1* ^K51A^, mCH‐*GBP1* ^C589A^, or mCH‐*GBP1* ^Δ589--592^ variants or monocyte‐derived macrophages (MDMs) stained for endogenous GBP1. Cells were infected with type I or type II *Toxoplasma gondii* (*Tg*) for 2 h. Blue, Nuclei; Gray, *Tg*; Red, mCH‐GBP1; or Magenta, GBP1. Scale bar, 5 μm. Graph in (B) shows mean percentage of *Tg* vacuoles targeted by GBP1 from *n* = 4 experiments. *\*\*\*\*P *≤ 0.0001 for indicated comparisons by two‐way ANOVA.](EMBJ-38-e100926-g008){#embj2018100926-fig-0004}

GBP1 targets *Salmonella*‐containing vacuoles and mediates caspase‐4‐dependent pyroptosis {#embj2018100926-sec-0006}
-----------------------------------------------------------------------------------------

To better understand common determinants of GBP1 in influencing host cell death responses to infection, we investigated its role during STm infection. STm infection causes inflammasome‐driven pyroptosis in macrophages (Franchi *et al*, [2006](#embj2018100926-bib-0026){ref-type="ref"}; Miao *et al*, [2006](#embj2018100926-bib-0063){ref-type="ref"}; Broz *et al*, [2010](#embj2018100926-bib-0007){ref-type="ref"}). In agreement with previous studies (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}), IFNγ‐priming of THP‐1 cells enhanced pyroptosis and IL‐1β release by \~ 1.5--2 fold after infection by STm at various bacterial MOIs (Figs [5](#embj2018100926-fig-0005){ref-type="fig"}A and [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}E--G). Expression of GFP by STm did not affect pyroptosis (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}E) ruling out non‐specific effects of GFP and allowed us to use this strain in our studies which also included immunofluorescence microscopy. Like THP‐1 cells, IFNγ‐priming of primary MDMs also enhanced STm‐induced IL‐1β release and pyroptosis (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}F and G). We tested the involvement of GBP1 in these processes by RNAi in primary MDMs ([Appendix Fig S1A](#embj2018100926-sup-0001){ref-type="supplementary-material"}) and infection of THP‐1 Δ*GBP1* cells. In all cases, loss of GBP1 expression abolished IFNγ‐mediated enhancement of pyroptosis and reduced it to levels seen without IFNγ‐priming (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}B). Together with our results on *Tg* infection, these findings pointed toward a broader role for GBP1 in host cell death during microbial infections.

![GBP1 targets *Salmonella* vacuoles and mediates caspase‐4‐dependent pyroptosis\
ALDH release assay from the indicated THP‐1 cells untreated or treated with IFNγ and infected with *Salmonella* Typhimurium (STm) WT or a SPI‐1 mutant Δ*invA* for 4 h at indicated multiplicities of infection (MOI). Mean ± SEM of *n* = 3 experiments are shown.BPropidium iodide (PI) uptake assay from IFNγ‐primed primary MDMs transfected with non‐targeting control siRNA (CTRL) or siRNA against *GBP1* (left) or indicated THP‐1 cells (right) infected with STm‐GFP for 4 h. Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments.CPI uptake assay from IFNγ‐primed primary MDMs transfected with indicated siRNA or non‐targeting control (CTRL) and infected with STm‐GFP for 4 h. Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 4 independent experiments.DPI uptake assay from IFNγ‐primed or untreated THP‐1 Δ*CASP1* cells transfected with the indicated siRNA and infected with STm‐GFP for 4 h. Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments. Schematic on right shows overview of the pathway leading to caspase‐1 and caspase‐4 activation.ELDH release assay from the indicated THP‐1 cells treated with IFNγ and Dox and infected with STm‐GFP for 4 h. Shown is the mean ± SEM of *n* = 3 experiments.F, GRepresentative images (F) and quantification (G) from IFNγ‐primed THP‐1 Δ*GBP1* cells stably reconstituted with Tet‐mCH‐*GBP1*, mCH‐*GBP1* ^K51A^, mCH‐*GBP1* ^C589A^, or mCH‐*GBP1* ^Δ589--592^ variants or primary MDMs stained for endogenous GBP1. Cells were infected with STm‐GFP for 2 h. Blue, Nuclei; Gray, STm; Red, mCH‐GBP1; or Magenta, GBP1. Scale bar, 5 μm. Graph in (G) shows percentage of STm vacuoles targeted by GBP1.HQuantification of GBP1 recruitment to STm‐GFP‐containing vacuoles (SCV) in MDMs pre‐treated with IFNγ or left untreated (UT). Mean ± 95% CI of GBP1 fluorescence intensity measured on the indicated number (*n*) of SCVs for each condition from three independent experiments is shown. \*\*\*\**P* \< 0.0001 by nested *t‐*test.IRepresentative images from THP‐1 Δ*GBP1 *+* *Tet‐mCH‐*GBP1* cells stably expressing YFP‐CASP4^C258S^. Cells were infected with STm for 2 h. Blue, Nuclei & STm (Hoechst dye); Red, mCH‐GBP1; Green, YFP‐CASP4^C258S^. Scale bar, 5 μm.JQuantification of THP‐1 Δ*GBP1 *+* *Tet‐mCH‐*GBP1* cells stably expressing YFP‐CASP4^C258S^ and infected with STm for 2 h. Graph shows percentage of STm vacuoles targeted by GBP1, CASP4, or both from *n* = 3 experiments. n.d. not detected.Data information: *\*\*\*P* ≤ 0.001, *\*\*\*\*P* ≤ 0.0001 for indicated comparisons by two‐way ANOVA in (B--D, G), comparison between untreated and IFNγ‐treated in (A) or THP‐1 WT, and other genotypes in (E) by one‐way ANOVA following adjustment for multiple comparisons; ns, not significant.](EMBJ-38-e100926-g010){#embj2018100926-fig-0005}

Mechanistically, unlike *Tg*, STm‐induced cell death was abolished by GSDMD silencing in primary MDMs and THP‐1 cells (Figs [5](#embj2018100926-fig-0005){ref-type="fig"}C and [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}H, and [Appendix Fig S1A and B](#embj2018100926-sup-0001){ref-type="supplementary-material"}), which established that STm‐infected naïve and IFNγ‐primed macrophages undergo pyroptotic cell death. Importantly, in naïve cells, silencing of caspase‐1 or GSDMD reduced STm‐induced cell death by \~ 60%, whereas silencing of caspase‐4 had no effect (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}C), which indicated that unprimed macrophages infected with STm underwent solely caspase‐1‐dependent pyroptosis. In contrast, in IFNγ‐primed THP‐1 and primary MDMs, only the combined silencing of caspase‐1 and caspase‐4 could completely block STm‐induced cell death, which pointed to the involvement of both caspases under these conditions (Figs [5](#embj2018100926-fig-0005){ref-type="fig"}C and [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}I, and [Appendix Fig S1A and B](#embj2018100926-sup-0001){ref-type="supplementary-material"}). During these experiments, we observed that in IFNγ‐primed cells, silencing of either caspase‐1 or caspase‐4 reduced pyroptosis to levels seen in naïve cells (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}C). We therefore reasoned that IFNγ‐induced GBP1 might promote the detection of STm by the noncanonical caspase‐4--caspase‐1 pathway and enhanced GSDMD processing by both caspases. The existence of a GBP1/caspase‐4‐dependent pathway was independently supported by experiments in IFNγ‐primed THP‐1 Δ*CASP1* cells which underwent enhanced STm‐induced cell death in response to IFNγ‐priming which was abolished upon GBP1 silencing (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}D and [Appendix Fig S1B](#embj2018100926-sup-0001){ref-type="supplementary-material"}). These findings together indicated that in IFNγ‐primed macrophages, STm infection engaged both caspase‐1 and caspase‐4 and this required GBP1 (schematic in Fig [5](#embj2018100926-fig-0005){ref-type="fig"}D).

We next asked whether GBP1 GTPase activity and isoprenylation contributed to pyroptosis. Indeed, THP‐1 Δ*GBP1* cells expressing GBP1^K51A^, GBP1^C589A^, or GBP1^Δ589--592^ did not undergo STm‐induced pyroptosis, whereas no such defects were observed in cells expressing GPB1^RK227/228EE^ or GBP1^K382R^ (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}E). Furthermore, endogenous GBP1 translocated to STm‐containing vacuoles (SCV) in MDMs (Fig [5](#embj2018100926-fig-0005){ref-type="fig"} and G). GBP1 expressed in basal levels in MDMs (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}B) can traffic to SCVs. However, IFNγ‐priming, which increased the abundance of GBP1 protein (Fig [EV1](#embj2018100926-fig-0001ev){ref-type="fig"}B), increased the proportion of decorated SCVs by 2‐fold (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}G) and also the amount of GBP1 on individual SCVs (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}H). mCH‐GBP1, but not GTPase‐dead or isoprenylation‐deficient variants, recruited to SCVs in THP‐1 Δ*GBP1* cells (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}F and G). This suggested that targeting of microbial vacuoles and the same molecular functions of GBP1 were required to mediate apoptosis during *Tg* infection and pyroptosis during STm infection. Importantly, GBP1 did not affect nigericin‐induced NLRP3‐dependent pyroptosis (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}J). This indicated that, like in the context of apoptosis, the role of GBP1 was restricted to regulating infection‐induced cell death.

We asked whether GBP1 promoted caspase‐4 trafficking to SCVs and addressed this using THP‐1 ∆*GBP1 *+* *Tet‐mCH‐*GBP1* cells stably transduced with catalytically inactive YFP‐caspase‐4^C258S^ (Fig [EV4](#embj2018100926-fig-0004ev){ref-type="fig"}K); stable expression of YFP‐caspase‐4 led to toxicity. YFP‐caspase‐4^C258S^ translocation could be detected on 37% of SCVs within 2 h of infection in Dox‐ and IFNγ‐primed cells (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}I and J). Remarkably, caspase‐4 recruitment was completely absent in cells lacking GBP1 (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}J). Moreover, YFP‐caspase‐4^C258S^ was only recruited to STm that was also decorated with GBP1 (Fig [5](#embj2018100926-fig-0005){ref-type="fig"}J), which resulted in a high Pearson\'s correlation coefficient for colocalization of GBP1 and caspase‐4 on GBP1/caspase‐4 double‐positive STm (0.76 ± 0.08, *n* = 529 SCVs). Taken together, we concluded that in IFNγ‐primed cells, GBP1 not only traffics to STm, but also promotes the recruitment and activation of caspase‐4.

GBP1 can be bypassed by direct delivery of *Toxoplasma* lysate or bacterial LPS into the cytosol {#embj2018100926-sec-0007}
------------------------------------------------------------------------------------------------

Our results showed that GBP1 recruitment to PVs and SCVs correlated with its ability to promote pathogen‐dependent cell death. Based on work on murine Gbps (Meunier *et al*, [2014](#embj2018100926-bib-0060){ref-type="ref"}, [2015](#embj2018100926-bib-0061){ref-type="ref"}; Man *et al*, [2015](#embj2018100926-bib-0058){ref-type="ref"}), we hypothesized that GBP1 contributed to the release of microbial ligands for detection by AIM2 or caspase‐4 in the cytosol of human macrophages (Liu *et al*, [2018](#embj2018100926-bib-0054){ref-type="ref"}). To obtain experimental support for this, we asked whether GBP1 could be bypassed by transfecting cells with soluble *Tg* antigen (STAg) or LPS. Indeed, STAg transfection led to IFNγ‐dependent cell death as measured by AnnV‐Glo in MDMs and THP‐1 cells and pointed toward the requirement of an IFNγ‐induced factor for sensing STAg ligands (Fig [EV5](#embj2018100926-fig-0005ev){ref-type="fig"}A and B). As levels of caspase‐1 were reduced upon *Tg* infection, we transfected STAg in Δ*CASP1* cells to mimic *Tg* infection. Indeed, like natural *Tg* infection, STAg transfection triggered IFNγ‐dependent apoptosis in Δ*CASP1* cells (Fig [6](#embj2018100926-fig-0006){ref-type="fig"}A). To identify which component of STAg was required for apoptosis, we treated STAg with DNase, RNase, trypsin, or a mix of deglycosylation enzymes prior to transfection. DNase‐treated STAg failed to induce apoptosis in Δ*CASP1* cells and established an essential role of *Tg* DNA in this process (Fig [6](#embj2018100926-fig-0006){ref-type="fig"}B). We further verified this by immunoblots and AnnV‐Glo assays to detect apoptosis following STAg transfection of Δ*CASP1* cells silenced for the expression of *AIM2*,*ASC*,*CASP8,* or *GBP1*. These experiments revealed that STAg induced GBP1‐independent and AIM2‐, ASC‐, CASP8‐dependent activation of the apoptosis cascade (Fig [6](#embj2018100926-fig-0006){ref-type="fig"}C and D). Taken together, these experiments reconstituted *Tg*‐induced apoptosis in Δ*CASP1* cells and pointed to the detection of *Tg* DNA in the cytosol by AIM2. Furthermore, loss of caspase‐1 protein during *Tg* infection contributed to the switch in AIM2‐dependent pyroptosis to apoptosis.

![Transfection of pathogen‐derived ligands bypasses the requirement for GBP1 in cell death\
A, BAnnexin V (AnnV)‐Glo assay kinetic of primary monocyte‐derived macrophages (MDM) transfected with non‐targeting control (CTRL) or *GBP1* siRNA (A) and THP‐1 or Δ*GBP1* cells (B) and transfected with soluble *Toxoplasma gondii* antigen (STAg). Cells were unprimed or primed with IFNγ before experiments. Mean ± SEM from area under the curve (AUC) of 18‐h real‐time assays plotted from *n* = 4 independent experiments.CPropidium iodide (PI) uptake assay from indicated THP‐1 cells left untreated (UT), treated with LPS or transfection reagent (Lipofectamine) only, or transfected with LPS (for 4 h) with IFNγ‐priming. Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments.DIL‐1β ELISA from THP‐1 cells transfected with non‐targeting control (CTRL) or *GBP1‐5* siRNA as indicated which were left untreated or primed with IFNγ and transfected with LPS. Mean ± SEM from area under the curve (AUC) of 24‐h real‐time assays plotted from *n* = 3 independent experiments.Data information: *\*\*\*\*P *≤ 0.0001 from two‐way ANOVA following adjustment for multiple comparisons; ns, not significant.](EMBJ-38-e100926-g011){#embj2018100926-fig-0005ev}

![Transfection of pathogen‐derived ligands bypasses GBP1 in inducing macrophage death\
Cell death measured using Annexin V (AnnV)‐Glo assay of THP‐1 Δ*CASP1* cells transfected with non‐targeting control (CTRL) or *GBP1* siRNA and treated as indicated. Cells were primed with IFNγ, transfected with soluble *Tg* antigen (STAg) or both, or left untreated (UT). Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments.AnnV‐Glo assay from naïve or IFNγ‐primed THP‐1 Δ*CASP1* cells transfected with soluble *Tg* antigen (STAg) that was untreated (UT) or treated as indicated. Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments.Immunoblots from IFNγ‐primed THP‐1 Δ*CASP1* or THP‐1 Δ*ASC* cells transfected with non‐targeting control (CTRL), *GBP1*,*AIM2*,*CASP1,* or *CASP8* siRNA and then untreated (−) or transfected with STAg for 12 h. Images are representative of *n* = 2 independent experiments.AnnV‐Glo assay from naïve or IFNγ‐primed THP‐1 Δ*CASP1* cells transfected with non‐targeting control (CTRL), *GBP1*,*AIM2*,*CASP1,* or *CASP8* siRNA and then untreated (UT) or transfected with STAg as indicated for 18 h. Area under the curve (AUC) from real‐time assay plotted as mean ± SEM from *n* = 3 independent experiments. Schematic on right shows an overview of pathways leading to caspase‐8 activation.Propidium iodide (PI) uptake assay from MDMs transfected with non‐targeting control (CTRL) or *GBP1* siRNA and then left untreated (UT), treated with LPS or transfection reagent (Lipofectamine) only, or transfected with LPS for 4 h. Area under the curve (AUC) from real‐time assays plotted as mean ± SEM from *n* = 4 independent experiments. Schematic on right shows an overview of pathways leading to caspase‐4 activation.Data information: *\*P* ≤ 0.05; *\*\*\*\*P *≤ 0.0001 from two‐way ANOVA following adjustment for multiple comparisons; ns, not significant.Source data are available online for this figure.](EMBJ-38-e100926-g012){#embj2018100926-fig-0006}

We performed similar experiments by transfecting LPS to assess the role of GBP1 in promoting caspase‐4 activation. LPS transfection of MDMs (Fig [6](#embj2018100926-fig-0006){ref-type="fig"}E) and THP‐1 (Fig [EV5](#embj2018100926-fig-0005ev){ref-type="fig"}C) led to GBP1‐independent pyroptosis which was in contrast to the role of GBP1 during natural infection with STm. As a control, we verified that IL‐1β production by LPS transfection was reduced by GBP5 silencing as has been described before (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}; Santos *et al*, [2018](#embj2018100926-bib-0084){ref-type="ref"}; Fig [EV5](#embj2018100926-fig-0005ev){ref-type="fig"}D). Altogether, our results showed that GBP1 acted as a gatekeeper and promoted the release of or access to microbial ligands for cytosolic receptors such as AIM2 and caspase‐4 which trigger pathogen‐specific cell death pathways.

Discussion {#embj2018100926-sec-0008}
==========

Here, we report that human GBP1 acts as an upstream regulator of diverse forms of cell death in macrophages and promotes the activation of microbe‐specific downstream pathways. The access to or release of microbial ligands in infected macrophages required GBP1, which therefore acts a gatekeeper of microbe‐induced cell death. GBP1 joins GBP2 and GBP5 in regulating human macrophage pyroptosis, but uniquely also regulates the induction of apoptosis. Our results highlight the contribution of IFNγ priming, the host species, and microbial pathogen to macrophage cell death. For instance, in naïve cells, *Tg* induces necrosis in mouse embryonic fibroblasts (Zhao *et al*, [2009](#embj2018100926-bib-0104){ref-type="ref"}), pyroptosis in rat and murine macrophages (Cavailles *et al*, [2014](#embj2018100926-bib-0010){ref-type="ref"}; Cirelli *et al*, [2014](#embj2018100926-bib-0012){ref-type="ref"}; Ewald *et al*, [2014](#embj2018100926-bib-0020){ref-type="ref"}; Gorfu *et al*, [2014](#embj2018100926-bib-0031){ref-type="ref"}), and pyroptosis in human monocytes (Witola *et al*, [2011](#embj2018100926-bib-0100){ref-type="ref"}; Gov *et al*, [2017](#embj2018100926-bib-0034){ref-type="ref"}). In contrast, *Tg* infection of IFNγ‐stimulated human foreskin fibroblasts causes an unspecified form of cell death (Gov *et al*, [2013](#embj2018100926-bib-0033){ref-type="ref"}; Niedelman *et al*, [2013](#embj2018100926-bib-0066){ref-type="ref"}). We also found that during STm infection, IFNγ enhanced macrophage pyroptosis in a GBP1‐dependent manner. Importantly, both pathogens relied on similar molecular determinants of GBP1 to promote host cell death.

GBP1, GBP2, and GBP5 have C‐terminal CaaX motifs that undergo isoprenylation. GBP1 also undergoes GTP‐dependent oligomerization (Daumke & Praefcke, [2016](#embj2018100926-bib-0016){ref-type="ref"}). We showed that GBP1 GTPase activity and lipidation are essential for its role in targeting of microbial vacuoles and mediating host‐cell death. These findings ascribe additional biological relevance to GBP1 lipidation as demonstrated from *in vitro* experiments with unilamellar vesicles and association with phagosomes (Shydlovskyi *et al*, [2017](#embj2018100926-bib-0089){ref-type="ref"}) and STm in HeLa cells (Bradfield, [2016](#embj2018100926-bib-0005){ref-type="ref"}). A similar role for lipidation of GBP5 for its recruitment to LPS OMVs and mouse Gbp1/2 for trafficking to microbial vacuoles has been identified previously (Finethy *et al*, [2017](#embj2018100926-bib-0024){ref-type="ref"}; Lindenberg *et al*, [2017](#embj2018100926-bib-0053){ref-type="ref"}; Santos *et al*, [2018](#embj2018100926-bib-0084){ref-type="ref"}). The correlation of microbe‐targeting and cell death in our studies mirrored similar findings on mouse and human GBPs that target bacteria and restrict their replication in a GTPase‐ and isoprenylation‐dependent manner (Kim *et al*, [2011](#embj2018100926-bib-0043){ref-type="ref"}; Finethy *et al*, [2015](#embj2018100926-bib-0023){ref-type="ref"}; Li *et al*, [2017](#embj2018100926-bib-0051){ref-type="ref"}; Piro *et al*, [2017](#embj2018100926-bib-0073){ref-type="ref"}; Wandel *et al*, [2017](#embj2018100926-bib-0098){ref-type="ref"}). Interestingly, the recruitment of GBP1 to *Tg* vacuoles is cell‐type specific, as it was shown to target PVs in mesenchymal stem cells (Qin *et al*, [2017](#embj2018100926-bib-0074){ref-type="ref"}) but not in A549 lung epithelial cells (Johnston *et al*, [2016](#embj2018100926-bib-0040){ref-type="ref"}), which correlates with the ability of GBP1 to induce cell death upon targeting *Tg* vacuoles. Similarly, murine Gbps do not target *Chlamydia muridarum;* however, they are required for pyroptosis (Finethy *et al*, [2015](#embj2018100926-bib-0023){ref-type="ref"}). The exact mechanism by which GBPs interact with pathogen vacuoles and lead to their opening has been subject of previous studies (Yamamoto *et al*, [2012](#embj2018100926-bib-0102){ref-type="ref"}). However, no definitive mechanism has been identified. Our work provides additional evidence that GBP1 membrane interaction depends on its lipidation and GTPase activity, and suggest these properties contribute to vacuole opening. Further studies are needed to unravel factors that promote the loading of GBP1 onto microbial vacuoles and how GBPs restrict intracellular pathogens.

*Tg* induced AIM2‐, ASC‐, and caspase‐8‐dependent cell death in both primary MDMs and THP‐1 cells. We found that *Tg*‐infected macrophages formed ASC specks that contained active caspase‐8. The sustained expression of AIM2 in *Tg*‐infected macrophages and the loss of NLRP3 and caspase‐1 might suppress the newly described STING‐NLRP3‐dependent cell death pathway (Gaidt *et al*, [2017](#embj2018100926-bib-0027){ref-type="ref"}). In this alternative DNA‐sensing pathway, STING causes lysosomal damage‐induced cell death and NLRP3 activation. Indeed, transfection of *Tg* DNA in Δ*CASP1* cells triggered AIM2/ASC/caspase‐8‐dependent apoptosis, suggesting that loss of caspase‐1 alone was sufficient to switch the cell death mechanism. The role of other cytosolic DNA‐sensors in detecting *Tg* also needs be explored in the future (Roers *et al*, [2016](#embj2018100926-bib-0079){ref-type="ref"}). Similar to our findings on reduced NLRP3 activation in *Tg‐*infected macrophages, *Tg* can also suppress NLRP3 in neutrophils (Lima *et al*, [2018](#embj2018100926-bib-0052){ref-type="ref"}). Rat and mouse NLRP1B trigger *Tg‐*induced pyroptosis (Cirelli *et al*, [2014](#embj2018100926-bib-0012){ref-type="ref"}; Ewald *et al*, [2014](#embj2018100926-bib-0020){ref-type="ref"}; Gorfu *et al*, [2014](#embj2018100926-bib-0031){ref-type="ref"}) and human NLRP1 is implicated in the process in monocytes (Witola *et al*, [2011](#embj2018100926-bib-0100){ref-type="ref"}; Gov *et al*, [2017](#embj2018100926-bib-0034){ref-type="ref"}). Murine NLRP1B activation requires the liberation of its C‐terminal caspase‐1 activating region after undergoing self‐cleavage and selective proteasomal degradation of the N‐terminal fragment (Chui *et al*, [2019](#embj2018100926-bib-0011){ref-type="ref"}; Sandstrom *et al*, [2019](#embj2018100926-bib-0082){ref-type="ref"}). It is plausible that unknown *Tg* effectors fail to target monocyte NLPR1 and caspase‐1. We hypothesize that *Tg* causes the total depletion of caspase‐1, NLRP1, NLRP3, and NLRC4 through one or more uncharacterized *Tg* effector proteins in macrophages. Why the *Tg* effectors GRA35, 42, and 43, which are involved in inflammasome activation in rat macrophages (Wang *et al*, [2018](#embj2018100926-bib-0099){ref-type="ref"}), fail to do so in human macrophages needs to be addressed in the future.

STm activates the NAIP‐NLRC4 and/or NLRP3 pathways in mouse (Franchi *et al*, [2006](#embj2018100926-bib-0026){ref-type="ref"}; Miao *et al*, [2006](#embj2018100926-bib-0063){ref-type="ref"}; Broz *et al*, [2010](#embj2018100926-bib-0007){ref-type="ref"}) and human macrophages (Kortmann *et al*, [2015](#embj2018100926-bib-0045){ref-type="ref"}; Reyes Ruiz *et al*, [2017](#embj2018100926-bib-0078){ref-type="ref"}). Our studies pinpoint a role for GBP1 in the enhancement of pyroptosis by IFNγ stimulation, trafficking, and activation of caspase‐4 and confirm a previously described downstream role for GBP5 (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}). GBPs can contribute to cytokine processing and/or pyroptosis by assisting in the activation of inflammasomes (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}; Pilla *et al*, [2014](#embj2018100926-bib-0071){ref-type="ref"}; Feeley *et al*, [2017](#embj2018100926-bib-0021){ref-type="ref"}; Lagrange *et al*, [2018](#embj2018100926-bib-0049){ref-type="ref"}; Santos *et al*, [2018](#embj2018100926-bib-0084){ref-type="ref"}) or the release of microbial ligands by promoting microbial/vacuolar lysis (Meunier *et al*, [2014](#embj2018100926-bib-0060){ref-type="ref"}, [2015](#embj2018100926-bib-0061){ref-type="ref"}; Man *et al*, [2015](#embj2018100926-bib-0058){ref-type="ref"}; Balakrishnan *et al*, [2018](#embj2018100926-bib-0004){ref-type="ref"}; Liu *et al*, [2018](#embj2018100926-bib-0054){ref-type="ref"}). Importantly, both GBP1 and caspase‐4 target STm, and caspase‐4 targeting was GBP1‐dependent. We hypothesize that GBP1 facilitates the opening of the bacterial vacuole and serves an essential role in exposing LPS for detection by caspase‐4 (Shi *et al*, [2014](#embj2018100926-bib-0088){ref-type="ref"}). STm Δ*sifA*, which forms unstable vacuoles and enters the cytosol, is occasionally targeted by caspase‐11 in murine macrophages (Thurston *et al*, [2016](#embj2018100926-bib-0091){ref-type="ref"}). In contrast, human caspase‐4 can be activated in naïve macrophages infected with *Francisella* (Lagrange *et al*, [2018](#embj2018100926-bib-0049){ref-type="ref"}) or enteropathogenic *E. coli* (Goddard *et al*, [2019](#embj2018100926-bib-0030){ref-type="ref"})*,* and the absence of a major role for caspase‐4 in naïve macrophages infected with STm needs to be investigated further in the future.

We found that the role of GBP1 in cell death could be bypassed by transfecting molecules from *Tg* or STm, but not during natural infection, pointing to its role in liberating microbial ligands. Importantly, we have discovered microbe‐specific activation of divergent host‐cell death types downstream of GBPs. On a systemic level, depletion of macrophages by apoptosis and pyroptosis has advantages for both host and pathogen depending on the point‐of‐view. From the pathogen side, depletion of cells that constitute a major threat works to their advantage. On the host side, depletion of infected host cells reduces the number of infectious pathogens and limits the infection to one hot spot as infected macrophages no longer travel to other sites. Further, apoptosis may trigger a different adaptive immune response (Campisi *et al*, [2014](#embj2018100926-bib-0009){ref-type="ref"}), as compared to the exuberant inflammation triggered by pyroptosis, and contribute to the clearance of pathogens trapped in apoptotic cells by efferocytosis (Campisi *et al*, [2014](#embj2018100926-bib-0009){ref-type="ref"}). In summary, we establish that GBP1 targets microbial vacuoles and promotes different host cell death against diverse infectious agents. Our study expands the understanding of how IFNγ influences host cells during infection by two important pathogens.

Materials and Methods {#embj2018100926-sec-0009}
=====================

Cells and parasites {#embj2018100926-sec-0010}
-------------------

THP‐1 (TIB‐202, ATCC) were maintained in RPMI with GlutaMAX (Gibco) supplemented with 10% heat‐inactivated FBS (Sigma), at 37°C in 5% CO~2~ atmosphere. THP‐1 cells were differentiated with 50 ng/ml phorbol 12‐myristate 13‐acetate (PMA, P1585, Sigma) for 3 days and then rested for 2 days by replacing the differentiation medium with complete medium without PMA. Cells were not used beyond passage 20. HEK293T and human foreskin fibroblasts (HFF) were maintained in DMEM with GlutaMAX (Gibco) supplemented with 10% FBS at 37°C in 5% CO~2~ atmosphere. THP‐1 Δ*CASP1*, Δ*CASP4*, Δ*ASC* (Schmid‐Burgk *et al*, [2015](#embj2018100926-bib-0085){ref-type="ref"}), and *GSDMD^miR^* (Eldridge *et al*, [2017](#embj2018100926-bib-0019){ref-type="ref"}) were cultured as above. An overview of all cell lines made/used in this study is provided in [Appendix Table S1](#embj2018100926-sup-0001){ref-type="supplementary-material"}.

*Tg* expressing luciferase/eGFP (RH type I and Prugniaud (Pru) type II) or expressing tdTomato were maintained *in vitro* by serial passage on monolayers of HFF cells, cultured in DMEM with GlutaMAX supplemented with 10% FBS, at 37°C in 5% CO~2~. All cell culture was performed without addition of antibiotics unless otherwise indicated. Cell lines were routinely tested for mycoplasma contamination by immunofluorescence, PCR, and agar test.

Human macrophage isolation and culture {#embj2018100926-sec-0011}
--------------------------------------

For isolating primary human macrophages, peripheral blood mononuclear cells were extracted from leukocyte cones from healthy donors (NHS) via Ficoll (17544202, GE Healthcare) density gradient centrifugation. CD14^+^ Monocytes were extracted using magnetic microbeads (130‐050‐201, MACS Miltenyi). Monocytes were counted and seeded for 1 week in RPMI containing 10% human AB serum (H4522, Sigma), GlutaMAX (Gibco), penicillin/streptomycin (Gibco), and 5 ng/ml hGM‐CSF (130‐093‐864, Miltenyi). The medium was replaced after 2 and 5 days, to replenish the hGM‐CSF.

Cell treatments {#embj2018100926-sec-0012}
---------------

Cells were stimulated for 16 h prior to infection in complete medium at 37°C with addition of 50 IU/ml human IFNγ (285‐IF, R&D Systems). Treatments to induce apoptosis were performed with 50 ng/ml TNFα (210‐TA, R&D Systems) and 10 μg/ml cycloheximide (CHX, C7698, Sigma) or 0.5 μg/ml staurosporine (S4400, Sigma). The caspase inhibitor zVAD‐fmk (25 μM, 60332, Cell Signaling Technologies) or qVD (20 μM, ab141421, Abcam) was used. To chemically induce pyroptosis, cells were either treated with 10 μM nigericin (N1495, Invitrogen) or transfected with 100 ng LPS *Sm* (IAX‐100‐011, Adipogen) per 60,000 cells using Lipofectamine 2000 (11668027, Invitrogen). Induction of GBP1 expression in the Doxycycline‐inducible cells was performed with 200 ng/ml Doxycycline (D9891, Sigma), which is below the LD~50~ (6.4 μg/ml) of Dox for *Tg* (Chang *et al*, [1990](#embj2018100926-bib-0500){ref-type="ref"}). To entirely block translation for studying protein stability in time course experiments, the cells were treated with 50 μg/ml CHX.

*Toxoplasma gondii* infection {#embj2018100926-sec-0013}
-----------------------------

Parasites were routinely grown in HFFs and passaged the day before infection to obtain parasites with a high viability for infection. *Tg* tachyzoites were harvested from HFFs by scraping the cells and syringe lysing the cells through a 25G needle. Following syringe lysis, the *Tg* suspension was cleared of cell debris by centrifugation at 50 × *g* for 5 min and the supernatant transferred into a new tube. Parasites were pelleted by centrifugation at 500 × *g* for 7 min, washed with complete medium, centrifuged again, and finally re‐suspended in fresh medium. Viable parasites were counted with trypan blue and used for infection at a multiplicity of infection (MOI) of three for most experiments or 1 for immunofluorescence imaging. Infection was synchronized by centrifugation at 500 × *g* for 5 min. Two hours after infection, extracellular parasites were removed with three washes with warm PBS and then cells cultured in fresh medium.

*Salmonella* Typhimurium infection {#embj2018100926-sec-0014}
----------------------------------

STm strain SL1344 was transformed with pFVP25.1, which contains rpsM promoter driving GFPmut3 (Valdivia & Falkow, [1996](#embj2018100926-bib-0094){ref-type="ref"}), maintained under Ampicillin selection (11593027, Gibco), and grown on LB + Ampicillin agar plates. STm SL1344 WT strain was maintained under streptomycin (11860038, Gibco) selection and grown on LB + Streptomycin agar plates. STm SL1344 Δ*invA* strain (kind gift from Jorge Galán, Galán *et al*, [1992](#embj2018100926-bib-0028){ref-type="ref"}) was maintained under streptomycin and kanamycin (11815032, Gibco) selection and grown on LB + Kanamycin agar plates. The day before infection bacteria from a single colony were inoculated into 9 ml LB and grown overnight at 37°C. The overnight culture was diluted 1:20 into LB + 300 mM NaCl (746398, Sigma) and grown with shaking in a closed container until an OD~600~ of 0.9. Bacteria were harvested by centrifugation at 1,000 × *g* for 5 min and washed with serum‐free cell culture medium twice and re‐suspended in 1 ml medium without FCS. Cells were infected with STm at an MOI of 30, and infections were synchronized by centrifugation at 750 × *g* for 10 min. Infected cells were washed 30 min post‐infection three times with warm PBS (806552, Sigma) to remove extracellular bacteria, and fresh medium containing 100 μg/ml gentamicin (15750060, Gibco) was added for 1 h. Medium was then replaced with medium containing 10 μg/ml gentamicin and the infection continued for indicated times. Bacterial MOI used for infections were confirmed by plating on LB agar plates.

AnnV/PI flow cytometry {#embj2018100926-sec-0015}
----------------------

For flow cytometry, PMA‐differentiated 1 × 10^6^ THP‐1 cells were harvested using accutase (A6964, Sigma) and washed twice with warm PBS and once in AnnV binding buffer (10 mM HEPES pH 7.4, 140 mM NaCl, 2.5 mM CaCl~2~). Cells were re‐suspended in AnnV binding buffer containing 1:100 AnnV‐PacBlue (A35122, Invitrogen) and stained at 4°C in the dark for 15 min and washed twice with AnnV binding buffer. Cells were analyzed on a LSR Fortessa (BD Biosciences), and data were processed using FlowJo version 10.3 (FlowJo, LLC).

Live time‐lapse imaging of apoptosis {#embj2018100926-sec-0016}
------------------------------------

To measure apoptosis and caspase activity, THP‐1 cells were seeded in an ImageLock 96‐well plate (\#4379, Essen Biosciences) and differentiated as described above. Cells were then primed with 50 IU/ml IFNγ overnight and infected with type I or type II *Tg*‐expressing tdTomato as previously described. To measure caspase activity, NucView™ 488 caspase‐3 substrate was added to the medium (RPMI without phenol red + 10% FCS) to a final concentration of 5 μM. Following infection, the cell culture plate was placed in an IncuCyte® ZOOM (Essen Biosciences) and phase‐contrast and green fluorescence images recorded every 15 min over a time course of 18 h. Images were analyzed using the IncuCyte® ZOOM software (Essen Biosciences).

LDH and XTT assay {#embj2018100926-sec-0017}
-----------------

To determine cell viability and cell membrane integrity using XTT (Cell proliferation kit II, Roche) and LDH assays (Pierce LDH Cytotoxicity Assay Kit, 88953, Thermo Scientific), 25,000 THP‐1 cells were seeded per well in a 96‐well plate and differentiated with PMA. For both assays, cells were treated and infected in RPMI without FCS and without phenol red (11835, Gibco) to not interfere with the colorimetric measurements. For LDH assay, 24 h p.i. cell culture supernatant was harvested and cleared by centrifugation at 2,000 × *g* for 5 min, and 50 μl was used to perform LDH assay according to the manufacturer\'s instruction (absorption at 490 and 680 nm for correction). For XTT assay, the detection reagent was freshly prepared according to the manufacturer\'s instruction and added 24 h p.i. with *Tg*. Cells were then incubated at 37°C for 4 h, and absorption was measured at 475 and 660 nm for correction.

AnnV glow assay {#embj2018100926-sec-0018}
---------------

Apoptosis kinetics were analyzed using the RealTime‐Glo™ Annexin V Apoptosis Assay (JA1001, Promega) according to the manufacturer\'s instruction. To do so, 0.06 × 10^6^ cells were seeded per well of a white, tissue culture‐treated 96‐well plates, differentiated, pre‐treated, and infected as described before. Simultaneously with infection, detection reagent was added. Luminescence was measured using a Fluostar Omega plate reader (BMG Labtech). No‐cell, medium‐only controls were used for background correction.

Real‐time propidium iodide (PI) uptake assays {#embj2018100926-sec-0019}
---------------------------------------------

To measure live kinetics of necrotic cell death, 0.06 × 10^6^ cells were seeded per well of a black‐wall, clear‐bottom 96‐well plate (Corning) and differentiated with PMA, pre‐treated, and infected as described above. Just before the start of the assay, medium was replaced with RPMI without phenol red and supplemented with 5 μg/ml propidium iodide (PI, P3566, Invitrogen). Then, the plate was sealed with a clear, adhesive optical plate seal (Applied Biosystems) and placed in a plate reader (Fluostar Omega, BMG Labtech) pre‐heated to 37°C. PI fluorescence was recorded with top optics every 15 min for times as indicated.

Immunoblotting {#embj2018100926-sec-0020}
--------------

For immunoblotting, 0.5 × 10^6^ cells were seeded per well of a 48‐well plate and differentiated with PMA, pre‐treated, and infected as described above. At the end of treatments, cells were washed with ice‐cold PBS and lysed for 5 min on ice in 50 μl RIPA buffer supplemented with protease inhibitors (Protease Inhibitor Cocktail set III, EDTA free, Merck) and phosphatase inhibitors (PhosSTOP, Roche). Lysates were cleared by centrifugation at full speed for 15 min at 4°C and transferred into a new tube. Cleared lysates (diluted 1:5) were used for BCA assay (Pierce BCA protein assay kit, 23225, Thermo Scientific) to determine protein concentration. Samples (10 μg of total protein) were run on 4--12% Bis‐Tris gels (Novex, Invitrogen) in MOPS running buffer and transferred on Nitrocellulose membranes using iBlot transfer system (Invitrogen). Depending on the primary antibody used, the membranes were blocked with either 5% BSA (A2058, Sigma) in TBS‐T or 10% dry‐milk (M7409, Sigma) in TBS‐T for at least 1 h at room temperature. Incubation with primary antibodies was performed at 4°C overnight (all antibodies used in this study can be found in [Appendix Table S2](#embj2018100926-sup-0001){ref-type="supplementary-material"}). To develop the blots, the membranes were washed with TBS‐T, probed with 1:5,000 diluted secondary antibodies in 5% BSA in TBS‐T, and washed again. Finally, the membranes were incubated for 2 min with ECL (Immobilon Western, WBKLS0500, Millipore) and luminescence was recorded on a ChemiDoc MP imaging system (Bio‐Rad).

To perform immunoblots on culture supernatants, cells were infected/treated in OptiMEM (1105802, Gibco) without serum. Proteins in the supernatants were precipitated with 4× volume ice cold acetone (V800023, Sigma) overnight at −20°C, and pelleted by centrifugation at full speed for 10 min at 4°C. Pellets were air‐dried for 10 min and re‐suspended in 40 μl 2× Laemmli loading dye and used for immunoblotting.

Quantitative RT--PCR (qRT--PCR) {#embj2018100926-sec-0021}
-------------------------------

RNA was extracted from 0.25 × 10^6^ cells using Trizol reagent (15596026, Invitrogen). GlycoBlue (5 μg/ml, AM9516, Invitrogen) was added during the isopropanol (190764, Sigma) precipitation step to enhance precipitation. RNA quality was measured on a Nanodrop 2000 Spectrophotometer (Thermo Scientific). RNA (1 μg) was reverse transcribed using the high‐capacity cDNA synthesis kit (4368813, Applied Biosystems). qPCR used the PowerUP SYBR green (A25742, Applied Biosystems) kit, 20 ng cDNA in a 20‐μl reaction, and primers ([Appendix Table S3](#embj2018100926-sup-0001){ref-type="supplementary-material"}) at 1 μM final concentration on a QuantStudio 12K Flex Real‐Time PCR System (Applied Biosystems). Primer specificity was ensured by designing primers to span exon--exon junctions whenever possible, and for each primer pair, a melt curve was recorded and compared to *in silico* predicted melt curve using uMelt (Dwight *et al*, [2011](#embj2018100926-bib-0501){ref-type="ref"}). Recorded C~t~ values were normalized to the recorded *C* ~t~ of human *HPRT1* and data plotted as Δ*C* ~t~ (Relative expression).

siRNA transfection {#embj2018100926-sec-0022}
------------------

Cells were transfected with siRNAs 2 days prior to infection; at the same time, the THP‐1 differentiation medium was replaced with medium without PMA or MDM differentiation medium was replaced on day 5 after seeding. All siRNAs were used at a final concentration of 30 nM. To prepare the transfection mix, a 10× mix was prepared in OptiMEM containing the appropriate siRNA(s) and TransIT‐X2 transfection reagent (MIR 600×, Mirus) in a 1:2 stoichiometry. As the GBPs exhibit high sequence similarity, we created a custom transfection panel using three different silencer select siRNAs (Ambion):

GenesiRNA 1Conc.siRNA 2Conc.siRNA 3Conc.Final Conc.*GBP1*s562020 nMs56215 nMs56225 nM30 nM*GBP2*s562320 nMs56245 nMs56255 nM30 nM*GBP3*s562610 nMs562710 nMs562810 nM30 nM*GBP4*s418057.5 nMs4180615 nMs418077.5 nM30 nM*GBP5*s418085 nMs4180912.5 nMs4181012.5 nM30 nM

The appropriate negative control was *Silencer*™ Select Negative Control No. 1 siRNA (\#4390843, Ambion).

All other siRNAs used in this study were OnTarget Plus smart pool siRNAs (Dharmacon):GeneCat. numberGeneCat. number*CASP1*L‐004401*CASP9*L‐003309*CASP2*L‐003465*CASP10*L‐004402*CASP3*L‐004307*NLRP1*L‐004423*CASP4*L‐004404*NLRP3*L‐017367*CASP5*L‐004405*NLRC4*L‐004396*CASP6*L‐004406AIM2L‐011951*CASP7*L‐004407*GSDMD*L‐016207*CASP8*L‐003466Negative controlD‐001810

Creation of THP‐1 Δ*GBP1* {#embj2018100926-sec-0023}
-------------------------

### Plasmid construction for generation of GBP1‐deficient THP‐1 cells {#embj2018100926-sec-0024}

Oligonucleotides used for creation of the cells are listed in [Appendix Table S4](#embj2018100926-sup-0001){ref-type="supplementary-material"}. GBP1‐deficient cells were generated with the pX330 plasmid CRISPR/Cas9 system. The insert fragment of GBP1 gRNA1 or GBP1 gRNA2 was generated by annealing oligonucleotides and cloned into the *Bbs*I site of the cloning vector containing U6 promoter to generate gRNA‐expressing plasmids pGBP1_gRNA1 and pGBP1_gRNA2, respectively. The *Xho*I and *Sal*I insert from the pGBP1_gRNA2 vector was cloned in the *Xho*I site of the pGBP1_gRNA1 vector to generate pGBP1_gRNA1/2 plasmid. The *Kpn*I and *Mlu*I fragment from pGBP1_gRNA1/2 was cloned into the *Kpn*I and *Mlu*I sites of pEF6‐hCas9‐Puro vector (Ohshima *et al*, [2014](#embj2018100926-bib-0068){ref-type="ref"}).

### Generation of GBP1‐deficient THP‐1 cells by CRISPR/Cas9 genome editing {#embj2018100926-sec-0025}

1 × 10^6^ THP‐1 cells were electroporated with 10 μg of the pEF6‐*hCas9‐Puro* vector containing target gRNA1/2 using NEPA21 (Nepa Gene). 48 h post‐electroporation, 3 μg/ml puromycin was added for 10 days to select for cells with a stable integration. Cells were plated in limiting dilution in 96‐well plates to isolate single cell clones. To confirm complete target gene deficiency, the targeted locus was sequenced, and the GBP1 protein expression analyzed by immunoblotting.

Creation of Dox‐inducible GBP1 cell lines {#embj2018100926-sec-0026}
-----------------------------------------

### Cloning of the Doxycycline‐inducible system {#embj2018100926-sec-0027}

To reduce leaky expression in the absence of Dox and maintain high responsiveness to Dox, we combined two transactivator proteins in one control vector: the transcriptional activator *rtTA2* ^*S*^ *‐M2* that induces expression in the presence of Dox and the silencer *tTS* that suppresses expression in the absence of Dox. *rtTA2* ^*S*^ *‐M2* was amplified by PCR from pBSKΔB‐*CAG‐rtTA2* ^*S*^ *‐M2‐IRES‐tTSkid‐IRES‐Neo* \[Addgene \#62346, a gift from Hiroshi Ochiai (Ochiai *et al*, [2015](#embj2018100926-bib-0067){ref-type="ref"})\], *tTS* from *UbC‐TRE‐mSOD2‐tTS‐IRES‐EGFP* \[Addgene \#12390, a gift from Zuoshang Xu (Xia *et al*, [2006](#embj2018100926-bib-0101){ref-type="ref"})\], *P2A* and *T2A* from pSpCas9(BB)‐*2A‐GFP* (PX458) \[Addgene \#48138, a gift from Feng Zhang (Ran *et al*, [2013](#embj2018100926-bib-0075){ref-type="ref"})\], and *bsr* from pHH3‐*SP‐lox‐GFP‐lox* \[a gift from Anthony Holder (Knuepfer *et al*, [2017](#embj2018100926-bib-0044){ref-type="ref"}) with 30 bp overlaps to each other using Q5 DNA‐polymerase (M0491, NEB)\]. pLSC‐5 \[Addgene \#62889, a gift from Feng Zhang (Zetsche *et al*, [2015](#embj2018100926-bib-0103){ref-type="ref"})\] which has an EFsNS promoter was digested with *EcoR*I and *Kpn*I to remove the sgRNA cassette and re‐ligated with repair oligonucleotides and then amplified the backbone with 30 bp overlaps to parts of our new insert without the *splitCas‐9* ORF. A 6‐fragment Gibson assembly with home‐made Gibson master mix created the pTet‐ctrl plasmid (with *rtTA2* ^*S*^ *‐M2‐P2A‐tTs‐T2A‐bsr* fusion gene under the control of EFsNS promoter in a vector backbone suitable for lentiviral transduction into mammalian cells). All oligonucleotide sequences used for cloning can be found in [Appendix Table S4](#embj2018100926-sup-0001){ref-type="supplementary-material"}.

To create a response vector, we used pLSC5 without the sgRNA cassette and replaced the *splitCas‐9* ORF with a Zeocin resistance gene (*shBle*) by Gibson assembly \[*shBle* was amplified from pSpCas9(BB)*‐2A‐GFP* (pX458)\] to generate pLSC‐5‐*Zeocin*. The tet response element (TRE) consisting of a minimal CMV promoter downstream of a heptamerized tet‐operator (Gossen & Bujard, [1992](#embj2018100926-bib-0032){ref-type="ref"}) from WT *HA‐dynamin 1 pUHD10‐3* \[Addgene \#34688, a gift from Sandra Schmid (Damke *et al*, [1995](#embj2018100926-bib-0015){ref-type="ref"})\] and pLSC‐5‐*Zeocin* were used for Gibson assembly to generate a plasmid (pLenti‐Tet) suitable for lentiviral transduction into mammalian cells that contains a TRE promoter and the Zeocin resistance under control of an EFsNS promoter. Finally, a multiple cloning site was inserted in the *Bam*HI and *Eco*RI sites downstream of the TRE to make the vector more versatile.

### GBP1 plasmids {#embj2018100926-sec-0028}

To create plasmids that express GBP1 under the control of Dox, RNA from IFNγ‐treated THP‐1s was extracted and cDNA was synthesized. The CDS of the *GBP1* mRNA was amplified with Q5 polymerase and the amplicon treated with Taq polymerase (M0273, NEB) to create A overhangs. Subsequently, the amplicon was cloned into pCR2.1®‐TOPO TA vector using TOPO TA kit (451641, Invitrogen). Next, GBP1 mutants were created by site‐directed mutagenesis, introducing single point mutations. Using the mutated or WT *GBP1*‐containing vectors, the ORFs were amplified using oligonucleotides to create overhangs to pLenti‐Tet vector. The target vector itself was digested using *BamH*I. We then performed Gibson assembly of the digested backbone and the *GBP1* ORFs and confirmed successful cloning by sequencing. To create mCH‐tagged versions, we additionally amplified *mCH* ORF with overlaps to the backbone and *GBP1* and included it in the Gibson assembly reactions.

### Lentiviral transduction of the Dox‐inducible system {#embj2018100926-sec-0029}

Lentiviral packaging used HEK293T cells transfected with required plasmids, pMD2.G (Addgene \#12259, a gift from Didier Trono) and psPAX2 (Addgene \#12260, a gift from Didier Trono) using Lipofectamine 2000 in serum‐free DMEM. Medium was replaced 12 h post‐transfection with fresh DMEM + 10% FBS to rest the cells. Medium was replaced again after 12 h with DMEM + 10% FBS containing 5 mM sodium butyrate (B5887, Sigma) to boost virus production and left for another 12 h. Medium was replaced with RPMI + 10% FBS and the cells left to produce lentiviral particles for 1 day. Virus‐containing supernatant was filtered through a 0.43‐μm syringe filter and supplemented with 8 μM polybrene (H9268, Sigma). The THP‐1 Δ*GBP1* target cells were then re‐suspended in 500 μl of the virus‐containing medium and "spinfected" for 30 min at 720 × *g* before being placed back in the incubator. One hour p.i. 1 ml complete medium was added, and the cells left to rest. This infection procedure was repeated for a total of three times before selection with 15 μg/ml Blasticidin S (15205, Sigma). Once untransduced control cells had died in the selection medium, the newly created THP‐1 Δ*GBP1 *+* *Tet cells were then transduced with the *GBP1* ORF‐containing response vectors (pLenti‐Tet) following the same procedure and selection was performed using 200 μg/ml Zeocin (J67140, Alfa Aesar).

Creation of YFP‐*CASP4*‐expressing cell lines {#embj2018100926-sec-0030}
---------------------------------------------

### Cloning of YFP‐CASP4 retroviral vectors {#embj2018100926-sec-0031}

CASP4 and CASP4^C258S^ ORF was amplified by PCR (Pallett *et al*, [2017](#embj2018100926-bib-0069){ref-type="ref"}) from plasmids kindly gifted by Mitchel Pallett and cloned into pMX‐CMV‐YFP \[CMV‐driven expression of YFP derived from pEYFPC1 (Clontech; Eldridge *et al*, [2017](#embj2018100926-bib-0019){ref-type="ref"}) via sequence‐ and ligation‐independent cloning (SLIC)\]. CASP4^C258S^ mutation was generated by cloning two overlapping PCR fragments (by Mitchel Pallett) and was used as template for PCR to generate plasmid pMX‐CMV‐YFP‐CASP4^C258S^.

### Retroviral transduction of caspase‐4 into THP‐1 cells {#embj2018100926-sec-0032}

Caspase‐4‐encoding plasmids and the packaging plasmids pCMV‐MMLV‐pack (Shenoy *et al*, [2012](#embj2018100926-bib-0087){ref-type="ref"}) and pVSVg were transfected into HEK293T cells in serum‐free DMEM using Lipofectamine 2000 at a ratio of 5:4:1, to produce retroviral particles for transduction. Medium was replaced 12 h post‐transfection with fresh DMEM + 10% FBS to rest the cells. Medium was replaced again after 12 h with DMEM + 10% FBS containing 5 mM sodium butyrate to boost virus production and left for another 12 h. Medium was replaced with RPMI + 10% FBS and the cells left to produce lentiviral particles for 1 day. Virus‐containing supernatant was filtered through a 0.43‐μm syringe filter and supplemented with 8 μM polybrene. The THP‐1 Δ*GBP1 *+* *Tet‐mCH‐*GBP1* target cells were then re‐suspended in 500 μl of the virus‐containing medium and "spinfected" for 30 min at 720 × *g* before being placed back in the incubator. One hour p.i. 1 ml complete medium was added, and the cells left to rest. This infection procedure was repeated for a total of three times before selection with 1 μg/ml puromycin. Once untransduced control cells had died in the selection medium, the newly created cells were tested by immunoblotting and subsequently used for experiments.

IL‐1β and IL‐18 ELISA {#embj2018100926-sec-0033}
---------------------

To measure the production and secretion of cytokines by infected THP‐1s, the cell culture supernatant was harvested and cleared by centrifugation at 2,000 × *g* for 5 min. The cleared supernatants were then diluted in the buffer provided with the ELISA kits, and ELISA was performed according to the manufacturer\'s instruction. IL‐1β ELISA kit was from Invitrogen (\#88‐7261, detection range 2--150 pg/ml), and IL‐18 ELISA was from R&D Systems (\#7620, detection range 12.5--1,000 pg/ml).

Fixed immunofluorescence microscopy {#embj2018100926-sec-0034}
-----------------------------------

For confocal imaging, 0.25 × 10^6^ THP‐1 cells were seeded on gelatin‐coated (G1890, Sigma) coverslips in 24‐well plates and differentiated with PMA. Following treatments and infection, cells were washed three times with warm PBS prior to fixation to remove any uninvaded pathogens and then fixed with 4% methanol‐free formaldehyde (28906, Thermo Scientific) for 15 min at room temperature. Following fixation, cells were washed again with PBS and kept at 4°C overnight to remove any unreacted formaldehyde. Fixed specimens were permeabilized with PermQuench buffer (0.2% (w/v) BSA and 0.02% (w/v) saponin in PBS) for 30 min at room temperature and then stained with primary antibodies for 1 h at room temperature. After three washes with PBS, cells were incubated with the appropriated secondary antibody and 1 μg/ml Hoechst 33342 (H3570, Invitrogen) diluted in PermQuench buffer for 1 h at room temperature. Cells were washed with PBS five times and mounted using 5 μl ProLong™ Gold Antifade Mountant (P36930, Invitrogen).

For imaging of caspase‐8 recruitment to ASC specks, FITC‐IETD‐fmk (88‐7005‐42, Invitrogen) was added to the culture medium 1 h prior to fixation. Cells were then fixed and stained as detailed above.

Specificity of the home‐made GBP1‐antibody was validated by staining IFNγ‐primed THP‐1 ∆*GBP1 *+* *Tet‐*GBP1* cells (express all GBPs but GBP1) that were additionally treated with Doxycycline as a positive control ([Appendix Fig S2](#embj2018100926-sup-0001){ref-type="supplementary-material"}).

Specimens were imaged on a Leica SP5‐inverted confocal microscope using 100× magnification and analyzed using LAS‐AF software. Images were further formatted using FIJI software.

Quantification of protein recruitment to pathogen vacuoles and ASC speck formation {#embj2018100926-sec-0035}
----------------------------------------------------------------------------------

Cells seeded as above were infected with *Tg* MOI = 1 and fixed 6 h p.i. or STm‐GFP MOI = 30 and fixed 2 h p.i. Nuclei were stained with Hoechst 33342 and coverslips mounted as described above. Images were acquired using a Ti‐E Nikon microscope equipped with LED‐illumination and an Orca‐Flash4 camera using a 60× magnification. All intracellular vacuoles of 100 fields of view were automatically counted based on whether they show recruitment of GBP1, caspase‐4, both, or no recruitment using HRMAn high‐content image analysis (Fisch *et al*, [2019](#embj2018100926-bib-0025){ref-type="ref"}). Further, the analysis pipeline was used to measure the fluorescence intensity of GBP1 on STm vacuoles using the radial intensity measurement implemented in HRMAn. The Pearson\'s correlation coefficient for colocalization analysis was also computed on cropped STm vacuoles, that have been classified as decorated with both proteins by HRMAn, using Fiji. The experiment was repeated independently three times.

For quantification of ASC speck formation and caspase‐8 recruitment, 100 *Tg*‐infected cells were manually counted per condition using a Ti‐E Nikon microscope equipped with LED‐illumination using a 100× magnification based on whether they contain an ASC speck and whether caspase‐8 was recruited to this speck. The experiment was repeated independently three times.

STAg preparation, pre‐digestion, and transfection {#embj2018100926-sec-0036}
-------------------------------------------------

STAg was prepared as described previously (Gazzinelli *et al*, [1991](#embj2018100926-bib-0029){ref-type="ref"}). In brief, parasites from a confluent T25 flask were lysed by freezing at −80°C and thawing at 37°C followed by four 20‐s rounds of sonication. The resulting homogenate was centrifuged at 590 × *g* for 10 min, and supernatant collected. To deplete STAg of specific components, it was pre‐treated with either 5 U/rxn of Turbo DNase (AM2238, Invitrogen) to digest DNA, 10 μg/ml RNase A (EN0531, Thermo Scientific) to digest remaining RNA, trypsin (90057, Thermo Scientific) to digest proteins \[protease to protein ratio 1:20 (w/w)\], or with Protein Deglycosylation Mix II (P6044, NEB) to get rid of any glycosylation overnight. Untreated or pre‐treated STAg was then transfected into THP‐1s using Lipofectamine 2000 (1 μl STAg per well of a 96‐well plate).

Data handling and statistics {#embj2018100926-sec-0037}
----------------------------

Graphs were plotted using Prism 8.0.2 (GraphPad Inc.) and presented as means of *N* = 3 experiments (with usually three technical repeats within each experiment) with error bars representing SEM, if not stated otherwise. Data analysis used one‐way ANOVA, two‐way ANOVA, nested *t*‐test, or unpaired Student\'s *t*‐test as indicated in the figure legends. Benjamini, Krieger, and Yekutieli false‐discovery rate (*Q* = 5%)‐based correction for multiple comparisons as implemented in Prism was used when making more than three comparisons.
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